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7. GA         General Anaesthesia  
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11. MRM     Modified Radical Mastectomy  
12. NIBP      Non Invasive Blood Pressure  
13. NK           Neurokinin 
14. NMDA   N-methyl-d-aspartate  
15. NSAIDS   Non SteroidalAnti inflammatory Drugs  
16. PCA        Patient Controlled Analgesia  
17. PGE2     Prostaglandin E 2  
18. PHN       Postherpetic Neuralgia  
19. PVB       Paravertebral Block 
20. PONV     postoperative nausea and vomiting 
21. SpO2      Peripheral oxygen saturation  
22. SSEP      Somatosensory Evoked Potentials  
23. TPVB     Thoracic Paravertebral Block  
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ABSRACT 
 
Background 
                         General anaesthesia,is currently  used anaesthetic technique for  
surgical treatment of simple breast disease and breast malignancies.  Its  
limitations  in  the  form of  poorpostoperative  pain control,greater  incidence  
of   nausea,vomiting,prolongedrecovery  stays  andprolonged  hospitalizations.  
Parenteral  opioids  using  inearly postoperative period,it  leads to  increase   
incidence  of  nausea,vomiting  and  sedation  resulting  in  further prolongation 
of hospital stay. 
   Regional  anaesthesia using  paravertebral block,intercostalblock 
and epidural anaesthesia  has  been  suggestedas  an alternative tecnique in 
simple breast surgey.Regional techniques  reduces  postoperative pain leading 
to decreased requirement of analgesics thereby,indirectly leading to a reduction 
of postoperative nausea and vomiting( PONV). 
This  study was planned to assess the efficacy of  paravertebral block 
with bupivacaineand bupivacaine with clonidine used for  better surgical 
anaesthesia and  postoperative analgesia  in simple breast surgery. 
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Objectives of the study 
 To  assess onset of sensory blockade.  
 To assess  duration of  sensory blockade. 
 To assess intraoperative&postopeartive hemodynamic response. 
 To assess duration of analgesia. 
 To study the incidence of complications of paravertebral block. 
Materials and Methods 
Sixty patients  posted   for simple breast surgery  were allocated into two  
groups-Group  BC  (receiving 0.5% bupivacaine with clonidine in PVB) and 
Group B(receiving 0.5% bupivacaine  alone in PVB).Onset of sensory block 
was  assessed  using  Pinprick test.Duration of sensory block measured .  
Level of  postoperative  pain  was  assessed  using  Visual  Analogue  Scale 
(VAS).Complication of PVB measured . 
RESULTS 
Patient with Group  BC had faster onset of sensory block ,better 
intraoperative and postoperative haemodynamic response, prolonged duration of 
analgesia,when compared with group B. 
Both groups had no complications. 
Three failure of PVB block in patients of both the groups was recorded. 
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CONCLUSION  
       Patients receiving bupivacaine with clonidine and bupivacaine alone in 
PVB is provides better surgical anaesthesia and prolonged post operative 
analgesia, improved post operativerecovery,reduced hospital stay,when 
compared with general anaesthesia. 
Keywords  
Paravertebral,breastsurgery,sensory block, bupivacaine,clonidine,complication.   
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INTRODUCTION 
 
                Advancements in diagnostic sciences have lead to increased 
frequency in detection of  benign  breast  disease and malignancy  in women . 
After diagnostic confirmation, the vast majority of these patients undergo 
definitive surgery, mostly mastectomy or lumpectomy.  
The large number of patients hospitalized annually for surgical 
management of breast malignancy or breast disease entail heavy costs. Recent 
efforts are focused at containing hospital costs and reducing the length of 
hospital stay.   
               General anaesthesia (GA) is mostly used in surgical treatment of 
benign  breast disease and malignancies.  
The side-effects and complications of general anaesthesia such as post 
operative pain, nausea,vomiting,increases morbitity.These complication 
prolongs recovery room stays and necessitates hospitalization for patients.  
Most importantly, nausea and vomiting has been described by patients as 
most  deliberating than the operative procedure itself. 
In addition , general anaesthesia alone does not produce  adequate  
postoperative pain relief. Parenteral narcotic use is routine after emergence from 
anaesthesia and during the early postoperative interval , which further increases 
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the incidence of nausea, vomiting, sedation and results in prolonged recovery 
room and  stay. 
Regional anaesthesia using thoracic paravertebral block (TPVB) is an 
ideal alternative to general anaesthesia for benign breast disease and 
malignancies. 
Benefits include a reduction in intra operative and postoperative analgesic 
requirement, prolonged postoperative pain relief,thus improving post operative 
recovery and indirectly leading to reduced post operative nausea, vomiting and 
potential for early discharge .   
  Thoracic paravertebral block involves injection of local anaesthetic at 
the  site of emergence of spinal nerve , from  intervertebral foraminae.                                                                                   
The paravertebral space contains dorsal and ventral rami and the 
sympathetic chain. Hence, infiltration of this space results in unilateral sensory , 
motor and sympathetic blockade. 
 Paravertebral block has been used to relieve acute chest wall pain from 
rib fractures, herpes zoster , pleurisy , to manage acute and chronic post 
thoracotomy pain , and as an anaesthetic technique for surgery of the chest, 
breast and cholecystectomy.   
8 
 
Comparing Thoracic  epidural anaesthesia with paravertebral blocks in 
breast surgery, the adverse  effects of   hypotension and  urinary retention are 
significant problems  with epidural analgesia because of  bilateral blockade . 
 Pulmonary function are significantly better in the paravertebral group 
and stress responses, as measured by cortisol and glucose assay, are suppressed 
in the paravertebral group, but not in the extradural group .  
While comparing intercostal blocks with paravertebral blocks, intercostal 
block has inherent limitations of inadequate spread at multiple levels,   
inadequate analgesia and greater rates of complications of pleural or pulmonary 
damage . Intrapleural analgesia (injection of local anaesthetic between the 
pleurae) leads to significantly worsened pulmonary function in comparison to 
paravertebral block.  
    Paravertebral blocks are relatively easy to learn and perform , have  
low side effect and  no additional nursing surveillance. This leads to early  
discharge and reduce hospital stay. 
Immediatepostoperative analgesia is achieved  by preincisional PVB in 
patients who had undergone breast malignancy surgery. 
   Paravertebral nerve blocks achieve excellent pain relief and inhibit the  
neuroendocrine stress response to surgical manipulation. 
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         This study was to assess the efficacy of paravertebral block using  
clonidine  as adjuvant to bupivacaine for surgical anaesthesia and  better 
postoperative analgesia  in patients undergoing lumpectomy and simple 
mastectomy without axillary clearance. 
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AIM OF STUDY 
               
 
 To  assess onset of sensory blockade by using pinprick test in bupivacaine 
with clonidine and bupivacaine alone group for breast surgery. 
 To assess  duration of  sensory blockade 
 To assess intraoperative&postopeartive hemodynamic response 
 To assess duration of analgesia 
 To study the incidence of complications of paravertebral block .  
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REVIEW OF LITERATURE 
 
The history of breast malignancy is a long and far too often tragic one. 
The earliest recorded cases of the disease date back to ancient Egypt 3500 years 
ago. The three earliest documented cases arise from the famous Edwin Smith  
papyrus dating back to 1600 BC. Treatment in those days used to be 
cauterization of tumours with an instrument known as “the fire drill”. 
 In 460 BC, Hippocrates , the father of western medicine, described breast 
cancer as a humoral disease. For him, cancer was caused by the excess of black 
bile. He named the cancer “karkinos”, a Greek word for crab. 
In 200 AD, Galen described a large range of pharmaceuticals agents to 
treat breast cancer  . A number of physicians continued to search for the cause 
of the disease and an effective remedy . Francois de la BoeSylvius , Jean 
Astruc, Bernardino Ramazzini, Friedrich Hoffman, Giovanni Morgagni, 
Johanes de Gorter and Claude Nicholas Le Cat were few prominent among 
them.  
In 1757, Henri LeDran , a French physician , put forward the idea that 
surgery could actually cure breast cancer as long as the infected axillary lymph 
nodes were removed .  
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William Halsted of New York made radical breast surgery the gold 
standard in the year 1882. Jerome Urban proposed super radical mastectomy in  
1949.Alternative forms of surgery were also proposed from time to time as 
effective surgical remedies of breast cancer- they included prophylactic 
oophorectomy by George Beatson, adrenalectomy by Charles Huggins and 
hypophysectomy by Rolf Lefft and Herbert Olivecrona .   
Currently different types of treatment are available for patients with 
breast malignangy. Standard surgical techniques are wide local excision, 
lumpectomy, segmental mastectomy, total mastectomy,MRM with axillay 
dissection, radical mastectomy  .   
General anaesthesia is currently the standard technique used for surgical 
treatment of breast malignancy. Increasing hospital costs and stay have focused 
attention on reducing the length of hospital stay for these patients .  
Adverse effects and complications of general anaesthesia preclude 
ambulatory surgery for most patients undergoing breast surgery. 
 A 59% incidence of nausea and vomiting during the 24-hour interval 
after breast cancer surgery with general anaesthesia has been reported. This 
complication prolongs recovery room stays and necessitates hospitalization for 
patients otherwise able to undergo ambulatory surgery . Most importantly, 
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nausea and vomiting have been described by patients as more debilitating than 
the operative procedure itself.  
In addition , general anaesthesia alone cannot achieve adequate 
postoperative pain control. Parenteral narcotic use is routine after emergence  
from anaesthesia and during the early postoperative period , which further 
increases the incidence of nausea, vomiting, sedation and results in prolonged 
recovery and hospital stays.  
 Regional anaesthesia using paravertebral block is an ideal alternative to 
general anaesthesia for breast surgery. Benefits include  reduction in 
postoperative nausea,vomiting, pain and potential for early discharge. 
Acute pain management came into force as a speciality in 1988 in Seattle 
where Brain Ready published his concept of acute pain services 27 . Later in 
1990 with joint colleges‟, reported  the setting up of acute pain services was 
recommended at all hospitals.  
Pain has been introduced as the fifth vital sign and standards for pain 
management has been published by Joint Commission on Health Care 
Organization (JCAHO) in 2001. 
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HISTORY OF PAIN 
Pain derived from Latin word  -„Poena‟ means punishment. 
           CHARLES BELL and FRANCOIS MAGENDIE demonstrated that 
dorsal roots of the spinal cord transmit sensory information whereas ventral 
roots transmit motor information and the idea of specific neural pathway for 
painful sensations originated. 
Alpha 2 agonist have been used by veterinarians for many years for regional 
analgesia, but is being used in humans since 12 years. 
FIG 1 - PAIN PATHWAY 
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FIG 2 – PAIN PATHWAY 
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PHYSIOLOGY OF PAIN 
Pain is a complex phenomenon which includes sensory –discriminative and 
motivational – affective components.  
The sensory component depends on ascending projection of tracts like 
spinothalamic and trigeminothalamic tracts into the cerebral cortex. They 
perceive quality of pain and help to know location of stimulus, intensity and 
duration of stimulus. 
Affective component includes attention, arousal, somatic, autonomic reflex, 
endocrine and emotional changes 
Pain receptors (Nociceptors): 
Nociceptors are free nerve endings seen in the skin, muscles, viscera, joints and 
vasculature. Nociceptors detect the noxious stimulus due to the chemical, 
mechanical and thermal (heat & cold) changes.  
They can be classified into exteroceptors, which receive stimuli from skin 
surface and interoceptors that are located in the walls of viscera or deeper 
structures. These are free nerve terminals and are seen adjacent to small blood 
vessels and mast cells. Nociceptors operate as a functional unit with these. 
In addition to nociceptors, somatosensory receptors are located in the 
skin,which are sensitive to other forms of stimulation and each sensory unit 
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includes an end-organ receptor, accompanying axon, dorsal root ganglion, and 
axon terminals in the spinal cord. 
In Gate control theory; “Melzack and Wall (1965) proposed that inhibitory 
interneurons located in the superficial part of the dorsal horn played a crucial 
role in controlling incoming sensory information before it was transmitted to the 
brain through ascending pathways”. 
 Dorsal horn contains four major neuronal components: 
 The central terminals - primary afferent axons 
 Intrinsic neurons 
 Projection neurons 
 Descending axons that pass caudally from several brain regions. 
THE LAMINA OF REXED 
“Rexed (1952) divided the dorsal horn of the cat spinal cord into a series of six 
parallel laminae, based on differences in the size and packing density of neurons 
(cyto architectonics)”. 
“ Lamina II” can be subdivided into two parts,its inner (IIi) and outer (IIo). 
Laminae I and II are referred to as the superficial dorsal horn, constitute the 
main target for nociceptive primary afferents.” 
 The deeper laminae (III - VI) also have an important role in pain. Some 
nociceptive primary afferents terminate in this region, and many of the neurons 
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in these laminae including some projection cells are activated by noxious 
stimulation. 
“Lamina I, also called as marginal layer, forms a thin two dimensional sheet 
covering the dorsal aspect of the dorsal horn and contains both projection 
neurons and inter neurons”.A few large projection neurons are called as “giant 
marginal cells of Waldeyer.”  
Lamina II is also known as “the substantiagalatinosa, because the lack of 
myelinatedfibres within it gives it a translucent appearance in unstained 
sections”.  
Lamina III also contains a high density of neurons. Laminae IV - VI are more 
heterogeneous, with neurons of various sizes, some of which are projection 
cells. 
PRIMARY AFFERENT FIBRES 
 “The somata of primary sensory neurons that innervate the limbs and trunk are 
located in sensory gangliaassociated with spinal nerves (dorsal root ganglia). 
Their axons bifurcate within the ganglion giving rise to peripheral and central 
branch, where it forms synapses with second-order neurons. Fibres innervating 
skin are described as cutaneous sensory neurons”. 
Afferent fibres innervating abdominal or pelvic viscera are termed visceral 
afferents. 
19 
 
Cutaneous sensory neurons 
 “Myelinated low-threshold mechanoreceptors 
 Myelinated nociceptive afferent fibres  
 Unmyelinated afferent fibres” 
Receptors associated with primary afferent neurons 
 “Primary afferent fibres also possess a rich diversity of ligand-gated ionotropic, 
metabotropic and tyrosine kinase receptors which include both the alpha - 
amino - 3 - hydroxy - 5 - methyl - 4 - isoxazolepropionic acid (AMPA) and N - 
methyl - D - aspartate (NMDA) classes of ionotropic glutamate receptors and 
metabotropic glutamate receptors.” 
Lastly, α2 adrenergic receptors are also found in sensory neurons and are 
thought to be localised at the central terminals of peptidergic fibres. 
PROJECTION NEURONS, SUBSTANCE P AND THE NEUROKININ 1 
RECEPTOR 
Neurons with axons that project to the brain are present in large numbers in 
lamina I and are scattered through the deeper part of the dorsal horn (laminae III 
- VI) and the ventral horn. 
“Lamina I and some of the projection cells in deeper laminae, have axons that 
cross the midline and ascend to a variety of supra spinal targets including the 
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thalamus, the midbrain periaqueductal grey matter, lateral para-brachial area of 
the pons and various parts of the medullary reticular formation.” 
“Substance P is present in many nociceptive primary afferents and there is 
evidence that this peptide and the neurokinin I (NKI) receptor, on which it acts, 
have a significant role in spinal pain mechanisms”. 
“Substance P is released from primary afferents at extra synaptic sites and acts 
on NKI receptors on the projection neurons through volume transmission”. 
SPINAL INTERNEURONS 
“Interneurons make up the great majority of the neuronal population throughout 
the dorsal horn, laminae I - III contains a large number of interneurons since the 
packing density of neurons is particularly high”. 
Classification of interneurons inhibitory and excitatory interneurons: 
Inhibitory interneurons - divided into those that use GABA but not glycine as 
transmitters and that use both. 
 Excitatory interneurons are mostlyglutamatergic. 
GABA and GLYCINE receptors: 
GABAAand glycine receptors are situated   in the spinal cord and are probably 
expressed by all dorsal horn neurons. 
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DESCENDING MONOAMINERGIC AXONS: 
“Serotoninergic axons in the spinal cord originate in the medullary raphe nuclei, 
while those that contain norepinephrine are derived from cells in the locus 
ceruleus and adjacent areas of the pons”. 
        “Norepinephrine containing axons can be identified with antibodies against 
appropriate synthetic enzymes (eg. dopamine - β hydroxylase). They are found 
throughout the dorsal horn, with high density in laminae I and II”. 
Nerve block  provide analgesia over the entire area and may have the advantage 
of blocking the peripheral sensitization. Paravertebral block in breast surgery 
provides analgesia over the surgical field and by blocking noxious stimuli 
prevents peripheral sensitization. 
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THORACIC PARAVERTEBRAL BLOCK 
Thoracic  paravertebral block was  first performed by Hugo Sellheim Leipzig , 
in obstetric cases (especially LSCS) in 1905,as an alternative technique to 
neuraxial blockade. 
TPVB technique is performing  unilateralsympathetic,somatic  nerve blockade 
when  local anesthetic agent injectingnear to the spinal nerves along the 
intervertebral foraminae.Although TPVB have gained a good popularity in 
1920- 1930. 
It was reintroduced by Eason and Wyatt in 1979. 
PVB is used in the following  region:  
 Cervical  
 Thoracic (T1-T10)  
 
 Thoraco-lumbar (T11-L2)  
 
 Psoas compartment (L2-L5)  
 
TPVB technique is performing    unilateral sympathetic,somatic  nerve blockade 
when  local anesthetic agent injecting near to the spinal nerves along the 
intervertebral foraminae at unilateral paravertebral space .Two roots of Spinal 
nerves are dorsal sensory root and  ventral motor root. 
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 The dorsal sensory roots are divided into two branches,it passes through the 
transverse processes. 
The ventral motor roots, take the name of intercostal nerves.   
 
ANATOMY OF THORACIC  PARAVERTEBRAL SPACE 
 
Its  extends from T1 paravertebral space to T12  
Thoracic paravertebral space is triangular wedge-shaped. 
Superiorly-Costotransverse ligament 
                      Transverse process of vertebrae 
                      Anterolateral parietal pleura  
Posteriorly- intercostal membrane and adjacent ribs at superior and inferior. 
Base of this triangle  - Vertebral body,  
                                    Intervertebral disc  
                                    Intervertebral space at the medial. 
Left  sided thoracic paravertebral space is larger. 
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FIG – 3 ANATOMY OF PARAVERTEBRAL SPACE 
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It is separated into two compartments by  Endothoracic fascia. 
Anterior compartment- Extrapleural paravertebral compartment  
Posterior compartment - Subendotoracic paravertebral compartment . 
                           TPVS communicates medially with the epidural 
space,Laterally with the intercostal spaces. 
Thoracic paravertebral space contains  
                Adipose tissue, 
                Spinal nerves, 
                Sympathetic chain, 
                Intercostal vascular structures, 
Preganglionic white and postganglionic grey rami communicantes. 
FIG - 4 COMPARTMENT OF PARAVERTEBRAL SPACE 
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INDICATIONS  
Thoracic paravertebral block is used for surgical anaesthesia and postoperative 
analgesia. 
Primary indications as surgical anaesthesia 
 Simple breast disease excision, lumpectomy, mastectomy with     
axillarydissection,MRM.  
 Breast reconstruction and reduction surgery 
 Resections of chest wall disaese 
 Video-assisted  thoracoscopic surgery (VATS) 
 Upper extremity  orthopaedic surgery 
 Endovascular aortic aneurysm surgery  
Post operative pain control 
 In Thoracotomy. 
 Minimally invasive cardiac surgery  
 Cardiac surgeries including sternotomy , thoracotomy  
 Thoracoscopy 
 Flial chest 
 Inguinal hernioplasty 
 Lap or open cholecystectomy  
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 Post nephrectomy  
 Postherpetic neuralgia(PHN) 
 Infectious and neoplastic syndromes  
 Post mastectomy pain  
 Chronic postthoracotomy pain 
CONTRAINDICATIONS  
Absolute contraindication 
 Patient refusal  
 Infection at insertion site       
 Unspecified neuropathy 
 Allergy to local anesthetics 
 Major coagulopathy  
Relative  contraindication for TPVB 
 Coagulopathy 
 Bleeding disorders 
 Anticoagulants applied and kyphoscoliosis. 
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POSITION AND LANDMARKS 
TPVB  techniques performing following position of the patient 
                                        Sitting 
                                        Lateral decubitus  
                                        Prone position. 
Landmarks  
“The spinous process of  thoracic vertebrae are angled caudally such that the 
superior  aspect of the tip of the spinous process lies adjacent to the transverse 
process of  lower vertebrae . It means, tip of the spinous process of T1 is 
adjacent to the transverse process of T2”.  
“ For example if T2-T6 are to be blocked, a mid line between the superior level 
of theT1  and T5 spinous process is marked. The superior aspect of each spine is 
then marked along the line. A parasagittal line, parallel and 2.5cm lateral to the 
midline mark is drawn on the side to be blocked. A transverse process lies deep 
to each parasagittal mark”. 
In sitting position,head and neck are at flexion .Anasthesiologist  stands behind 
the patient . The conventional loss of resistance technique is used .  
The spinal processes of vertebras are marked with palpation at the level of T1-
T6 dermatomes.  
The points of needle insertions,  at a vertical plane parallel to midline at 2-2.5 
cm are also marked lateral to spinous process. 
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Parts were cleaned and painted with antiseptic solution. 
Sterile drapes were placed.  
Planned needle insertion point was infiltrated with local anaesthetic. 
Tuohy‟s epidural needle is perpendicularly inserted from skin to hitch  
transverse process at 3-5 cm depth.Syringe which is prefilled with air is 
connected to the Tuohy‟s epidural needle. 
After hitching the tranverse process ,needle is superiorly walked off and on 
advancement of needle for 0.5to1cm,a loss of resistance to air could be  elicited. 
Syringe was detached from  needle and drug was injected in. 
In single level block total volume of drug injected was 21 ml 
In multiple level block amount of drug injected was 3-4 ml/dermatome.   
At time of  injection , negative aspiration was done  to prevent  intravascular 
injection.   
Maximum dosage used was  3 mg/kg of body weight.  
Patient was then made to lie down supine. 
Onset of sensory anaesthesia occured 10 -15 minutes after the injection. 
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Table-1VARIOUS PARAVERTEBRAL BLOCK TECHNIQUES 
S.NO PARAVERTEBRAL BLOCK TECHNIQUES 
1 Blind technique 
2 Loss of resistance technique 
3 Nervestimulation techniques 
4 Ultrasound guided technique 
5 Pressure monitoring technique 
6 Fluoroscopic directly imaging technique 
7 Direct application technique at the time of 
thoracoscopy or thoracotomy or surgical placement 
 
DOSAGE AND SPREAD 
In multiple level injection ,the amount of localanesthetic agent needed for each  
dermatomes is 4 – 5 ml of 0.5% bupivacaine, 0.5% levobupivacaine, 2% 
lidocaine. 
For single level paravertebral block, 0.5% bupivacaine or 0.5%levo bupivacaine 
20-24 mL of local anesthetic used. 
The spread of drug in paravertebral space is usually cephalad and then caudal. 
“ Cloud” spread  in few segments,lateral spread to intercostal space and medial 
spread to epidural space may occur. 
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 In epidural injections; cephalic3-4 dermatomes and caudally 2-3 dermatomes 
spread are seen. 
But,in paravertebral block; cephalic2-3 dermatomes and caudal 3-4 dermatomes 
spread are seen. 
In our study,both the techniques of multiple and single level injection were 
used. 
If multiple level injected, the amount of localanesthetic agent has to be 
calculated  as 3-5 ml (0.5% bupivacaine with clonidine (2mics/kg ) or 0.5% 
bupivacanine alone) for each segment of respectivegroup. 
For single injection technique,  20-21 ml local anesthetic(0.5% bupivacaine 
with clonidine(2mics/kg) or 0.5% bupivacanine alone)  for complete block. 
Table 2 - Local anaesthetics used for PVB with typical onset, anaesthesia                               
and  analgesia times. 
Local Anaesthetic Onset 
time(min) 
Anaesthesia 
time / hours 
Analgesia 
time / hours 
Bupivacaine 0.5% 15-25 4-6 12-18 
Ropivacaine 0.75% 10-15 4-6 12-18 
Lidocaine 2% 10-15 2-3 3-4 
Mepivacaine 1.5% 10-20 2-3 3-4 
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COMPLICATIONS OF PARAVERTEBRAL BLOCK 
 “Failure of “PVB” (6.8 to 10% ) 
 Pneumothorax . 
 Bradycardia 
 Hypotension , because of  unilateral sympathetic blockade.  
 Accidentally intravascular  injection of local anaesthetic toxicitiy has 
ocurred. 
 When needle is introduced medially, dural puncture ocurred. This lead to 
Epidural spread or epidural anaesthesia, spinal anesthesia and postdural 
headache . 
 Unilateral Horner‟s syndrome is due to spread of  local anesthetic to    
ipsilateral stellate ganglion or preganglionic fibers. 
 Unilateral sensory  block in arms is due to spread of  local anesthetic to 
T1 segment of brachial plexus”. 
CLINICAL ADVANTAGES  
 “Learn easily and perform  PVB 
 Better than thoracic epidural administration 
 Complications  are less in PVB 
 In single level injection, developed unilateral somatic and sympathetic 
block in many dermatomes 
 Decreased stress and pressor response to surgical stimulae. 
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 Hemodynamic stability is better than GA 
 Lower extremity motor function is present  
 Bladder sensation is present 
 Early mobilization is possible 
 Less hospital stay”.                                                 
PHARMACOLOGY OF BUPIVACAINE 
Bupivacaine is an amide type local analgesic drug.  
It is a hydrochloride salt of 1-butyl-N-(2, 6-dimethylphenyl) piperidine-2- 
carboxamide.  
It was synthesized in Sweden by Ekenstam and his colleagues in 1957. 
First used clinically by L.J. Telivuo in 1963. 
Pka is 8.2 
Molecular weight     -  288 
Protein binding     -  95% 
Lipid solubility     -  28 
Elimination half life   -  210mts 
Toxic plasma concentration   -  >1.5µg/ml 
Approximate duration of action  -  175mts 
The drug is very stable to acids, alkalis and repeated autoclaving.  
 
Bupivacaine 0.5% is the preferred strength.  
 
Higher concentration result in greater variability of spread. 
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Bupivacaine is 4 times as potent as lignocaine, hence 0.5 % solution is  
 
approximately equivalent to 2 % lignocine. 
 
It is more cardiotoxic than lignocaine which is aggravated by hypoxia,  
 
hypercapnia and  pregnancy.It causes more sensory than motor block . 
 
It is not recommended for intravenous regional analgesia. 
 
 Duration of effect is between 5 and 16 hours and is one of the longest acting  
 
local analgesics, which is related to binding of it to the nerve tissue.  
 
Small percentage of a given dose of drug is excreted unchanged in the urine  
 
and the remainder is metabolised in the liver.  
 
Uses: 
 Spinal anesthesia 
 Epidural anesthesia 
 Caudal anesthesia 
 Continuous epidural anesthesia 
 Peripheral nerve block 
 Infiltration anesthesia 
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 Onset Time and Duration of Action 
 
 
 
 
 
 
 
FIG -5 STRUCTURE OF BUPIVACAINE 
 
 
 
 
 
 
 
 
 
Site of action Onset (minutes) Duration (minutes) 
Intrathecal 5 90-120 
Epidural 15-20 165-225 
Brachial plexus 10-20 600 
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Pharmacokinetics 
 
It gets absorbed through nerve rootlets and it is rapidly absorbed from the site of 
injection, but the rate of absorption depends on the vascularity and the presence 
of vasoconstrictors. 
Because of high lipid solubility it easily penetrates nerve and vascular tissue.  
80-95% of absorbed bupivacaine binds to the plasma proteins. 
Distribution: 
Rapid distribution phase: (α)  
Slow disappearance phase: (β) 
Biotransformation: 
Possible pathways of metabolism of bupivacaine include aromatic 
hydroxylation and conjugation.  
Only the N-dealkylated metabolite, N-desbutyl bupivacaine has been measured 
in blood (or) urine after epidural (or) spinal anesthesia.  
Alpha1 acid glycoprotein is the most important plasma protein binding site of 
bupivacaine. 
The concentration of bupivacaine is increased in many situations such as post 
operative trauma. 
Excretion: 
It is through the kidney, 4-10% of the drug is excreted unchanged. 
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Mode of Action 
a)Site of action   
i) The spinal nerve rootlet fine nerve filaments having a large surface area are 
exposed to local anesthesics. 
ii) Posterior and lateral aspects of  spinal cord. 
b)Sodium Channel blockade: 
They impede sodium ion access to the axon interior by occluding the 
transmembrane sodium channels thus delaying the process of depolarization and 
axon remains polarized. It is a non-depolarisation blockade. Thus the resting 
membrane potential is maintained and depolarization in response to stimulation 
is inhibited. 
The mechanism by which local anasthetics block sodium channel conductance 
is as follows, 
 Local anesthetics in the cationic form act on the receptors within the 
sodium channels, on the cell membrane and block it. The local 
anaesthetic can reach the sodium channel either via the lipophilic 
pathway directly across the lpid membrane or via the axoplasmic 
opening.This mechanism accounts for 90% of the nerve blocking effects 
of amide local anaesthetics. 
 The second mechanism of action is by membrane expansion .This is a 
non specific action in contrast to the more specific drug receptor 
interaction. 
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Pharmacodynamics: 
It has got a longer duration of action but a slower onset. 
Cardiovascular system: 
It reduces cardiac output by reducing the sympathetic tone, by slowing the heart 
rate and by reducing the venous return. 
It produces a fall in arterial blood pressure but it is relatively slow and is seldom 
very profound.  
It produces a fall in central venous pressure.  
It causes an increase in lower limb blood flow.  
It causes a reduction in incidence of deep vein thrombosis. 
Respiratory System 
It relaxes bronchial smooth muscle. It causes apnea due to phrenic and 
intercostal nerve paralysis or depression of the medullary respiratory center 
following direct exposure to drug. 
Gastro intestinal tract: 
There is an increase in gastro intestinal motility and emptying of the gastric 
contents are better. 
Toxicity: 
Toxicity is related to plasma level of unbound drug and more likely due to an 
inadvertant intravenous injection.  
Systemic toxicity reactions primarily involve central nervous system and cardio 
vascular system.  
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The blood level required to produce central nervous system toxicity is less than 
that required to produce circulatory collapse. 
Central Nervous System Toxicity: 
“Early symptoms are circumoral numbness, tongue paresthesia and dizziness. 
Sensory complaints include tinnitus and blurred vision.  
Excitatory signs (restlessness, agitation, nervousness, paranoia) often precede 
central nervous system depression (slurred speech, drowsiness, 
unconsciousness)”. 
Muscle twitching heralds the onset of tonic clonic seizures.  
Respiratory arrest often follows.  
The excitatory reactions are the result of selective blockade of inhibitory 
pathways. 
Cardiovascular System Toxicity: 
The rate of depolarization in fast conducting tissue of purkinje fibres and 
ventricular muscle is decreased.  
The rate of recovery of bupivacaine induced block is slower than that of 
lignocaine. 
Extremely high concentration of the drug causes sinus bradycardia, 
hypotension, AV block, idioventricular rhythms, and life threatening 
arrhythmias such as ventricular tachycardia, ventricular fibrillation and cardiac 
arrest. 
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TREATMENT OF BUPIVACAINE TOXICITY 
CNS toxicity  
Convulsions  treated by adequate ventilation with oxygenation, and controlled 
by anticonvulsantdrugs.Diazepam (10–20 mg IV, repeatedif necessary) or 
Alternatively, thiopental (150–250 mgintravenously) can be used.  Treatment 
includes mechanicalventilation and circulatory support, and the use of a  
vasopressor may be indicated. 
CVS toxicity         
If ventricular tachycardia, ventricular fibrillation and cardiac arrest occurred 
then , Bretylium is drug of choice.Phenytoin and Amiodarone are also used.   
Bupivacaine is highly protein binding and highly tissue binding mainly to 
cardiac tissue hence it will be unable to revive the patient even after effective 
resuscitation with adrenaline and vasopressin. 
Usage of 20% lipid emulsion will reduce the toxicity of bupivacaine by binding 
to it. 
Dosage and preparation 
The dosage of bupivacaine depends on, 
 Area to be anaesthetized 
 The vascularity of the tissue to be blocked 
 The number of neuronal segments to be blocked 
 Individual tolerance 
 Technique of local anesthesia  
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Available concentrations 
0.25%,0.5% 
0.25%,0.5% soluble in isotonic saline 
0.5% 0.75% solution in 8% dextrose hyperbaric 
These doses can be repeated in 3-4 hours but maximum dose is 400mg in 24 
hours. 
 
            Table:3  Dosage and concentration of bupivacaine in various blocks 
Type of block concentration Dosage in ml Dosage in mg 
Local infiltration 0.25-0.5% 5-20ml Upto 75 mg 
Brachial plexus block 0.25-0.5% 20-40ml 75-225 mg 
Intercostals block 0.25-0.5% 3-5ml 15-20mg per each nerve 
Epidural block 0.25-0.5% 15-20ml 50-225mg 
Caudal block 0.25-0.5% 15-30ml 75-150mg 
Subaracnoid block 0.5% 2-4 ml 10-20mg 
Paravertebral block 0.25-0.5% 15-20ml 50-225mg 
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                                                 CLONIDINE 
                           FIG 6 –STRUCTURE OF CLONIDINE 
 
History and chemistry 
Clonidine hydrochloride, an imidazoline derivative was introduced  as a nasal 
decongestant and vasoconstrictor.   
This  drug  is  related  to  the  drug  called  naphazoline, still  this  has  complex  profile  
of  actions.Its hypotensive and bradycardia effects were first appreciated  in 1962.  
It is a centrally acting adrenergic agonist that lowers blood pressure by decreasing basal 
sympathetic system activity. 
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It was introduced in Europe in1966 and subsequently in the U.S as an antihypertensive 
agent.(220:1 alpha2:alpha1) 
2-(2,6_-dichlorophenylamino)-2 – imidazoline hydrochloride.; 
C9H9C12N3 Hcl. 
Molecular weight :266.56 
It is an odourless ,white, bitter crystalline substance soluble in alcohol and water. 
 
Mechanism of action   
Alpha-2 adrenergic agonists produce clinical effects by binding to alpha -2 receptors . 
Three subtypes of alpha 2 receptors; 
 Alpha 2a-  sedation,analgesia,sympatholysis. 
 Alpha2b-vasoconstrction (antishivering mechanism) 
 Alpha 2c- startle response 
It is response of  body and mind  to  unexpected stimulus, such asloud noise, flash light. 
Effects are centrally mediated by  partial adrenergic agonist (alpha2:alpha1=200:1). 
The site for sedation is the pontine locus ceruleus of brain stem, where as principal site 
of analgesia is most likely spinalcord. 
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FIG 7- PHYSIOLOGY OF ALPHA-2 RECEPTORS 
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FIG 8 – ACTION OF ALPHA-2 RECEPTORS 
       
         
In the CNS, their main sites of action include the tractus solitarius (leading to 
hypotension and bradycardia),the locus coeruleus (causing sedation) and certain 
vagal nuclei.  
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In addition, they have profound analgesic effects.These may involve actions at spinal 
and supraspinal sites, including enhancement of descending inhibitorypathways to the 
dorsal horn, as well as the depression of thalamocortical pathways.  
Their peripheral effects decrease heart rate and reduce vascular smooth muscle 
tone.This leads to peripheral vasodilatation and bradycardia,hypotension,reduced 
cardiac output. 
Clonidine has the ability to modify  potassium channels in CNS and leads to 
hyperpolarisation of the membranes hence it reduces anaesthetic requirements.  
Clonidine inhibits release of  substance P and Sand neuron  firing produced by the 
noxious stimulation. This leads to analgesic effect. 
Clonidine also reduces  the cold response threshold by synchronous acting, while 
leading to mild elevation of the sweating threshold.It acts on the central 
thermoregulatory system rather than preventing shivering peripherally. 
Pharmacological effects 
Intravenous administration of clonidine produces a transient rise in blood pressure 
associated with peripheral vasoconstriction, an effect which is mediated by alpha1-
adrenoceptors. However, the secondary responses of bradycardia and hypotension are 
mainly due to agonist effects on alpha2 adrenoceptors in the CNS. 
 
Pharmacokinetics 
Clonidine is rapidly  absorbed after oral intake and has 100% bioavailablity.  
It attains peak plasma concentration  within 60 to 90 minutes 
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The elimination half life is around 9-12 hours. 
50% metabolized in the liver, 50% excreted in an unchanged form by the kidney. 
Its half life is increased in renal failure  and liver failure. 
Transdermal delivery system is available  in which the drug is released at a constant 
rate for about a week. Steady state concentrations will be achieved in three to four days. 
Side effects; 
              Sedation and xerostomia is most common 
              Fatigue,weakness,headache,withdrawal syndrome 
              Pallor ,weakly positive coombs test 
              Fever may also rarely occur. 
 CVS              orthostatic symptoms,palpitation,tachycardia,bradycardia,conduction 
abnormalities (i.e,junctional bradycardia,High degree Atrioventricular block and sinus 
node arrest)CCF and raynauds phenomenon syncope.  
CNS 
Nervousness, mental depression,insomnia,agitation  may occur. 
Other behavioral changes , vivid dreams or nightmares, hallucinations and delirium are 
rarely  reported. 
Dermatological  
     Rash, pruritis,angioneuroticedema and urticaria,alopecia. 
Gastrointestinal 
     Nausea, vomiting,anorexia,malaise,abnormalities in LFT ,constipation,abdominal 
pain rarely. 
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Genitourinary 
       Decreased sexual activity,impotence. 
Hematological 
    Reduced platelet count rarely.  
Metabolic 
     Weight gain,gynaecomastia, transient hyperglycemia , increased serum CPK 
 Musculoskeletal 
     Myalgia,arthralgia,leg cramps. 
INTERACTIONS WITH VARIOUS OTHER PHARMACOLOGICAL 
PREPARATIONS  
This  drug  may  also  like  other  ones  are  seen  to  be   reacting  with  other   different   
drugs   namely: 
 Tricyclic anti-depressant  drug  
 Chlorpromazine. 
 
Because  of  these  specific  interactions, the  intended  anti-hypertensive  nature  of  the  
drug  may  be  very  much  reduced  and  affected. 
Clonidine may cause bradycadia or AV block hence to be used in patients on 
digitalis,CCB,beta blockers with a caution. 
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Toxicology 
Some of the studies supported the occurence of spontaneous retinal degeneration  in 
albino rats treated with clonidine for more than six months. 
In some studies conducted in dogs and monkeys clonidine showed a high drug 
concentration in choroid ,but in human studies they documented  dryness of eyes only 
Electroretinography macular dazzle retinal function was normal. 
Over dosage 
Hypertension followed by fall in BP,HR,respiratory rate, temperature, altered 
consciousness,decreased or absent reflexes,seizures,weakness and miosis. 
Reversibe cardiac conduction abnormality,apnea,coma may occur. 
Toxic effects are developed within 30 minutes to two hours after exposure.  
In paediatric patients,even  a small dose of 0.1mg clonidine may produce toxic effects. 
Antidote 
There is no specific antidote for clonidine .  
Now adverse clinical effects can be reversed by ATIPAMAEZOLE( specific 
antagonist)in recently ingested patients.  
Gastric lavage ,activated charcoal may be useful. 
Supportive care may include anticholinergic  for bradycardia , IVF and  vasopressors  
for hypotension and vasodilators for hypertension.  
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Table - 4 Available formulation of clonidine 
 
Formulations Brand Dosage 
Oral tablets Clonidine tablets 0.1,0.2,0.3mg 
Transdermal patch Clonidine TTS 0.1,0.2,0.3g 
3mg/day 
Combination tablets Clonidine and 
chlorthalidone 
0.1,0.2 or 0.3 mg 
clonidine+15mg chlorthalidone 
Injection Cloneon , duraclon 500,150,100mcg/ml 
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Table - 5 Various routes of clonidine 
 
Route Dose 
Intranasal 2-4mcg/kg 
Intramuscular 2mcg/kg 
Oral 4-5mcg/kg 
Rectal 2.5-5mcg/kg with atropine 40mcg/kg 
Intravenous 1-2mcg/kg bolus or 0.18-3.16 mcg/kg/hrinfusion 
Caudal anaesthetic adjuvant 1-2mcg/kg 
Spinal anesthetic adjuvant 1-2mcg/kg 
Epidural anesthetic adjuvant 0.0625%bupivacaine with fentanyl 1mcg/ml and 
clonidine 0.6 mcg/ml 
Sciatic block 0.2% ropivacaine 0.4mg/kg/hr with clonidine 
0.12 mcg/kg/hr infusion 
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Anaesthetic uses of clonidine 
The anesthetic use of an alpha 2 adrenergic receptor agonist has been of recent research 
interest over last 20 years. 
1.Premedication 
It can be used as premedication.   
Clonidine‟s sedative effect is by activation of involved in sleep wake cycle. 
In addition it also has an anaesthesia sparing effect. 
It reduces the dose of intravenous hypnotic drugs and  MAC of  volatile anaesthetic 
agents. 
Clonidine has been recommended in doses of 4mcg/kg intranasally or orally and  
rectally in a dose of 5micg/kg  causes adequate sedation. 
Routine use of anticholinergic  with clondine reduces the incidence of bradycardia and 
hypotension. 
Its use as a premedicant is more useful in certain group of patients like,  
 Drug addicts and alcoholics,most of these patients have   withdrawal symptoms 
and sympathetic system  activity is high, when compared to normal patients. 
 Patients on  chronic opioid or analgesic treatment for cancer pain.These patients 
have increased analgesic requirement intraoperatively.. 
 Hypertensive patients. 
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2. Control of hemodynamic response 
Hemodynamic effects of clondineare both central and peripheral. 
Stimulation of the peripheral sub endothelial receptor causes vasoconstriction 
transiently. 
Stimulaton of alpha 2 adrenergic receptors of the neurons in the nucleus tractus 
solitaries causes inhibiton of nucleus of sympathetic neurons in the medulla,and 
reduces the baroreflex activity,decreases the atrial pressure hence leads to fall in heart 
rate. 
It is interesting to note that phasic activity of this reflex  is preserved.Hence any 
decrease  in arterial pressure is followed by a significant increase in heart rate. 
It depress presynaptic sympathetic neurons at  thoracic spinal cord level  ( lateral horn). 
Vasoconstrictors (eg.phenylephrine) and anticholinergics are used to treat the 
hypotension and bradycardia. 
Clonidine prevent stress response due to laryngoscopy, intubation, extubation and 
surgical stimulation . 
Patients undergoing cardiac surgery and vascular surgery have superior control of 
hemodynamics ,reduce the incidence of myocardial ischemia and decrease the morbidty 
and mortality. 
3 Post operative analgesia and regional anesthesia:  
It inhibit transmission of nociceptive stimuli in the dorsal horn of the spinal 
cord..clonidine has additive effect with opioids and augment local anesthetic blockade 
and prolong duration. 
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Epidural: 
 It can be used as whole anaesthetic agent to produce epidural analgesia in large doses 
(upto2-300mcg/day). 
At these dose hypotension ,bradycardia are common. 
It is more commonly used along with  local anesthetics and opioids at a dose of 10-15 
mcg/hr. 
Spinal: 
Compared to morphine intrathecal clonidine produces analgesia of shorter duration but 
without respiratory depression or urinary retention,along with local anesthetics 1-
2mcg/kg can be given. 
Caudal: 
Clonidine prolongs duration of  block without hemodynamic alterations.  The 
recommended dose is 1-2mcg/kg. 
Labor analgesia: 
Epidural clonidine can be used alone or  with opioids or local anesthetics . 
Clonidine crosses the placenta but not affect the newborn. 
The recommended dose is 100mcg during labor. 
Peripheral nerve blockade: 
Clonidine reduces the failure rate, and reduces local anesthetic dose requirement, 
prolonging sensory blockade  and duration of post operative analgesia. 
 A small dose of 2-3mcg/kg is sufficient which obviously reduce the risks of side 
effects. 
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 The quality of Bier‟s  block (IVRA)  by clonidine with lignocaine is improved. 
Addition of 150mcg clonidine has been found to enhance the tolerance.  
Other uses are 
 Prevention of emergence agitaton. 
 Decreasing minimum alveolar concentration of sevoflurane. 
 Postoperative nausea and vomiting (PONV). 
 Hypotensive anesthesia 
 In cardiovascular surgery; better hemodynamic stability in patients posted for 
cardiac surgery. 
 Prevent intraoperative shivering as well as post operative. 
 Day care surgery; 
 
 
 REVIEW OF LITERATURE 
 
        Darren Koh Liang Khai et al, studied, using the single level-injection thoracic 
paravertebralblock of ropivacaine 1% to provide analgesia in breast  surgery in Asian 
patients in the Singapore General hospital and  documented 32 cases scheduled for 
elective MRMwith axillary dissection. All patients received  20 ml ropivacaine 1% 
with adrenaline (5 ug/ml) injected into the paravertebral space  before   surgery. Also 
all  patient recieving  GA with conventional regimen. They Observed peri-operative 
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analgesic requirement,pain score, shoulder movement limitation, nausea or vomiting, 
and adverse effects of the block. 
             In another study, HuraG Knapiket al,seventy patients to received 
0.5%ropivacaine and 0.5% bupivacaine inPVB for MRM, onset of sensory block and 
duration of sensory blockade  was analysed  in both the group similar level of analgsia 
achieved. 
     
    GROUP 
ONSET OF SENSORY BLOCKAE 
WITH IN 5 MIN 
TOTAL DURATION OF SENSORY 
BLOCKADE > 24 HRS 
       R                  53%         81% 
       B                  20%         50% 
 
 
 
1.  
2. C. L. Burlacu ,H. P. Frizelle et al, study observed, fentanyl and clonidine in 
combination  with diluted levobupivacaine (0.05%)  in PVB are effective analgesic, 
lead to decreased requirement of  morphine consumption  post operatively.Low dose 
of fentanyl or clonidine in PVB was not associated  any  side-effects. 0.1% 
Levobupivacainealone in PVB is ineffective for postoperative analgesia after breast 
surgery. 
    Sang ii park et al, Non-obstetrical surgery is harmful to both the mother and the 
fetus,during first trimester. Anaesthetist also at stress , as the anaesthetic agents are  
harmful to fetus . A case of breast abscess  at  8 weeks pregnancy was successfully 
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treated by thoracic paravertebral block without any complications and  provided  with 
adequate post operative analgesia. Thoracic paravertebral block  is  safe anesthetic 
technique for non-obstetric surgery during early pregnancy. 
                  Pusch et al. described a singleinjection of a high volume of bupivacaine into 
the thoracic paravertebral space and reported effective anaesthesia for breast lump 
excisions as well as mastectomies with axillary dissection. 
              In a study conducted  by Pekka et al, a PVB with bupivacaine (1.5mg/kg) at 
T3, performed  before  general  anaesthesia  in  patients  scheduled  for  modified  
radical mastectomy(MRM),  resulted  in  less  need  for  postoperative opioid  
analgesics  in  the  first hours after sur gery and in  less overall intensity of pain on the 
first postoperative day. The fact  that  the  initial  postoperative  analgesia  was  
relatively  good  may  have  had  certain beneficial consequences. For instance, the 
smaller amount of opioid consumed by the PVB  patients  in  comparison  with  control  
patients,  was  probably  an  explanation  for  the  rapid  psychomotor  recovery  and  
infrequent  postoperative  nausea  and  vomiting  in  the patients given PVB with 
bupivacaine before surgery.  
          Rising  hospital  costs  have  focused  attention  on  the  length  of  stay  for  
patients  undergoing  surgical  treatment  of  breast  cancer. Thus  far,  ambulatory  
surgery  has  been  limited  by  side-effects  and  complications  of  general  anaesthesia.  
Paravertebral  block  offers  the  potential  of  effective  analgesia,  with  limited  
postoperative  nausea  and vomiting.  In  a  retrospective  study  involving  fifteen  
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patients  with  breast  cancer  who underwent sixteen major operations  for the treatment 
of breast cancer using paravertebral block,  Weltz  et  al  proved  that  paravertebral  
block  achieved  effective  anaesthesia  for cancer  operations  of  the  breast  and  axilla. 
Sensory  block  persisted  for  an  average  of  23 hours  and  postoperative  pain  was  
effectively  controlled.  In  nine  patients  were discharged home after an average 
recovery room stay of 169 mintues. All patients who underwent planned admission for 
postoperative observation were discharged by the morning after operation and one 
patient was discharged within four hours of operation 
In a retrospective analysis of 145 consecutive patients undergoing breast cancer 
operations using paravertebral block and 100 patients undergoing general anaesthesia 
during a 2-year period performed by Coveney et al, surgery was successfully 
completed in 85% of the cases attempted by using paravertebral block alone and in 
5.7% of the cases surgery was completed by using paravertebral block supplemented 
with local anaesthetic . PVB block resulted in a significantly shorter hospital stay than 
general anaesthesia for all operations. Forty four of the patients undergoing PVB 
(28.2%) were discharged on the day of surgery compared to 11% of the patients 
undergoing GA. In total, 3.8% of patients receiving PVB remained in the hospital for 
more than twenty four hours compared with 24% of patients undergoing GA.Narcotic 
analgesia was required in 98% of general anaesthesia patients as opposed to 25% of 
patients undergoing paravertebral block. Twenty percent of patients in the 
paravertebral group required medication for nausea and vomiting during their hospital 
stay compared with 39% in the general anaesthesia group. 
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Cosmetic and reconstructive breast augmentation is a frequently performed surgical 
procedure-especially in those women undergoing modified radical mastectomy for 
breast cancer.In a prospective,single blinded randomized trial by Klein et al, 
paravertebral block was found to provide improved analgesia during the first 24 hours 
after breast surgery when compared with GA ,along with lower nausea and vomiting 
scores which may in part be the result of improved analgesia and reduced intake of 
postoperative opioids.              
In another prospective ,randomized ,double blinded ,placebo controlled study 
comprising of eighty eight patients scheduled to undergo elective mastectomy, 
Moller et al  deduced that the group receiving multilevel paravertebral block prior to 
general anaesthesia required less intravenous fentanyl for intraoperative and 
postoperative analgesia in comparison to the group receiving only general 
anaesthesia.A multilevel injection PVB was shown to produce a more reliable 
sensory block than a single injection technique. Single injection techniques of 
paravertebral block are limited by the duration of action of the local anaesthetic. 
Recent improvements in the needle design and the introduction of disposable infusion 
pumps have facilitated the use of ambulatory perineural infusions after extremity 
surgery.  
Buckenmaier et al  described two case studies where both patients of breast cancer 
who underwent major breast surgeries were administered paravertebral block and an 
epidural catheter with an attached disposable infusion pump was secured .Infusion 
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was started at the end of surgery and continued for one additional postoperative day. 
Patients were discharged from hospital with clear instructions regarding local 
anaesthetic toxicity,pump function and catheter removal. Both the cases showed 
satisfaction with the anaesthetic technique. 
 
 D’Ercole and associates,in a case report , have mentioned use of PVB in a 
pregnant patient requiring modified radical mastectomy with axillary dissection. A 38 
yr old primigravida at 29 weeks of gestation presented with infiltrating ductal 
carcinoma grade 3 that required urgent left MRM. PVB was performed at T1-6 level 
and surgery was performed under sedation with intravenous propofol infusion .Both 
the intraoperative and the postoperative periods were uneventful. 
 
Good immediate postoperative analgesia is achieved by providing preincisional 
PVB in patients undergoing breast surgery for cancer. Good acute pain relief is 
associated with a lower risk of development of chronic pain in the operative area. 
Pekka et al, a prospective, randomized ,placebo-controlled, single blinded study 
involving sixty breast cancer patients undergoing breast surgery, administered PVB 
to one group before general anaesthesia and surgery, while the other group received a 
placebo block followed by general anaesthesia and surgery. A one year follow up was 
done postoperatively. Their follow-up showed that preoperative PVB reduced the 
prevalence and severity of pain upto one year after breast cancer surgery. Diagnostic 
and minor therapeutic breast surgery is usually performed in an outpatient setting. 
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The anaesthetic technique should aim at fast recovery and adequate postoperative 
pain relief. This cannot always be achieved with general anaesthesia which may be 
associated with considerable postoperative pain and a frequent incidence of 
postoperative nausea and vomiting. PVB seems to be a solution for these problems. 
 
In a prospective study conducted by Terheggen et al, thirty patients scheduled for 
elective, outpatient, minor breast surgery were randomized into two groups to receive 
either PVB or GA. Pain scores were significantly lower in the PVB group. The 
patient satisfaction score was significantly higher in the PVB group. 
Another similar study was conducted by Cooter and associates , where a total of 100 
patients undergoing submuscular breast augmentation were administered 
paravertebral blocks. This prospective study showed that 87% of the blocks were 
successful for surgical anaesthesia and 94% of the blocks were successful for 
postoperative analgesia. The pain scores were also significantly less, therby, 
suggesting PVB as a safe and effective anaesthetic technique for such minor 
surgeries. 
In a study conducted by Ebrahimy M & Moradi AR  for postoperative survey for 
the effective duration of the paravertebral block with bupivacaine in patients planned 
for mastectomy operations,the average duration of analgesia was seventeen hours and 
all the patients were pain free for the first eight hours after surgery. All the patients 
expressed their satisfaction with the procedure. 
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Hypertrophic obstructive cardiomyopathy (HOCM) places patients at significant risk 
of sudden cardiac death along with other cardiac disorders especially when placed 
under surgical stress. They can present with significant management difficulties. 
Buckenmaier and colleagues reported use of paravertebral block in a patient of 
HOCM who presented for partial mastectomy with axillary lymph node dissection. 
Compared to general anaesthesia PVB provides profound, long lasting sensory 
deafferentation. The resulting greater attenuation of the surgical stress response may 
translate into reduced iontropic stimulation of the heart.In comparison to the regional 
anaesthetic techniques 
such as spinal or epidural anaesthesia which produce bilateral sympathectomy 
resulting in profound hypotension ,difficult to treat in HOCM patients, PVB induced 
hypotension is a rare phenomenon 
In a study conducted by Greengrass et al,twenty five patients undergoing breast 
surgery were provided paravertebral block with sedation as an alternative to general 
anaesthesia .Postoperatively , patients had minimal nausea , vomiting and pain and 
the procedure was satisfactory for all patients. 
Buckenmaier and colleagues , in a study involving twenty patients undergoing 
mastectomy or breast lumpectomy with axillary dissection, used paravertebral block 
with infusions of 0.2% ropivacaine at 10 ml/hr. Infusions were continued for the 
patients during their home stay. Patients were contacted daily and again after one 
week following catheter removal and queried on visual analog pain scores (VAS) and 
narcotic use. All the patients were pleased with their pain control. This technique 
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achieved profound chest wall analgesia that extended beyond 24 hrs while still 
preserving the ambulatory status of the patients.  
 
          Thoracoscopic surgery can be associated with considerable postoperative pain . 
In a study conducted by Vogt and colleagues, forty patients planned for 
thoracoscopic surgeries were selected and divided randomly into two groups –one 
group receiving paravertebral block along with i.v. patient controlled analgesia 
(PCA) with morphine while other group was treated with a placebo block and 
morphine PCA. Paravertebral block improved postoperative pain treatment after 
thoracoscopic surgery in a clinically significant fashion. 
Neurological assessment after thoracic aortic aneurysm repair is important for 
detecting and treating late onset paraplegia .Traditional methods of pain control, such 
as patient – controlled intravenous analgesia and epidural analgesia, may interfere 
with neurological assessment.  In a case study conducted by Shine and colleagues, a 
patient who had a repair of thoracoabdominal aneurysm received continuous thoracic 
paravertebral analgesia that provided excellent analgesia while preserving the ability 
to monitor neurological function. In addition, it facilitated early extubation and 
maintainance of normal blood pressure with minimal use of adjuvant vasoactive 
medications. Analgesic methods that allow restitution of spontaneous ventilation 
improve venous return from vessels emanating from the spinal cord ,thus enhancing 
one aspect of spinal cord protection protection. Central neuraxial analgesia almost 
invariably affects hemodynamics, usually as a consequence of a significant 
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sympatholytic effect on capacitance vessels.The volumes of local anaesthetic 
required to maintain central neuraxial analgesia may also increase pressure within the 
central neuraxis, with possible detrimental effects on cord perfusion in pathologic 
circumstances.  
         Thoracic epidural analgesia may also affect the cardioaccelaratory fibres.It may 
also be contraindicated in the setting of thoracic abdominal aortic aneurysm repair 
because the large dose anticoagulation used in these procedures may increase the 
occurrence of central neuraxial hematoma. In contrast to both central neuraxial 
analgesia and systemic opioids, paravertebral analgesia provides intensive unilateral 
analgesia with infrequent neurological and hemodynamic effects.  
               Paravertebral blockade has been used for minimally invasive cardiac 
operations to facilitate early tracheal extubation. After minimally invasive coronary 
artery bypass procedures, paravertebral block is as effective as thoracic epidural 
blockade, with fewer side effects .When used for postthoracotomy analgesia, 
paravertebral blockades result in better preservation of pulmonary function than 
epidural analgesia. 
In a letter to the editor, Toshiyuki Saito has mentioned of a case study where a 
single injection paravertebral block has produced multisegmental analgesia The study 
involved 16 normal healthy human volunteers, in whom 22 ml of 1% lidocaine was 
administered at T 11 level in the paravertebral region. Analgesia, heart rate, blood 
pressure and body temperature were monitored. Volunteers were administered with 
control injection of paravertebral saline. Right sided analgesia was induced with 
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lidocaine in all subjects in contrast to no block with saline. Analgesia developed in a 
mean of 12 dermatomes with sympathetic blockade in at least 6 dermatomes. The 
cardiovascular response was no change in blood pressure or heart rate. There were no 
side effects or complications. Paravertebral block has been found to cause 
improvement in coronary perfusion. 
 In a case study conducted by Ho and colleagues, resolution of ST segment 
depressions after right thoracic paravertebral block during general anaesthesia was 
reported and attributed mainly to the paravertebral block- induced sympathectomy. 
The fact that ST segment depression resolved after the thoracic paravertebral block 
suggests that the block may have direct stenotic coronary artery dilating effects. 
The treatment of postherpetic neuralgia (PHN) continues to be a challenge in 
clinical pain management. In a case study involving one hundred thirty two patients 
with acute herpes zoster, Genlin Ji and coworkers assessed the effectiveness of 
repetitive paravertebral injections with local anaesthetics and steroids for the 
prevention of postherpetic neuralgia. The incidence of PHN was significantly lower 
in the paravertebral group . 
      In a case report, Borene and colleagues mentioned about a 51 yr old woman who 
developed severe lymphoedema and brachial plexopathy following modified radical 
mastectomy and radiotherapy for breast carcinoma. A continuous cervical 
paravertebral block was performed with good analgesic effects.The VAS score was 
never reported to be >2 after surgery and no systemic analgesics were required 
throughout the postoperative period 85. 
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In a case study by Meguiar and colleagues, bilateral lumbar paravertebral block was 
given to forty primigravidas during stage I of labour Good analgesia was obtained 
while maternal mean blood pressure and pulse were unchanged without any 
compromise of fetal well being and labour progressed rapidly. 
 
          Thoracotomy induces severe postoperative pain and impairment of pulmonary 
function. Risk of pulmonary complications may be reduced by adequate analgesia 
and physical therapy  . Since acute postoperative pain is also a predictor of long term 
pain after thoracotomy, early and aggressive treatment of pain may help to reduce 
high frequency of chronic pain . Although thoracic epidural analgesia is commonly 
considered the gold standard for postoperative pain treatment after thoracotomy,this 
technique may fail, be contraindicated or not be possible for a variety of reasons. 
Evidence has suggested that paravertebral block is also an effective technique for 
analgesia in thoracotomy, which is associated with fewer side effects than epidural 
analgesia.In a systematic review of randomized trials, Joshi and associates 
compared epidural versus paravertebral and other alternative regional analgesic 
techniques for postoperative pain,analgesic use and complications. Paravertebral 
block was found to have comparable analgesic effects with fewer side effects in 
comparison to epidural technique. 
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MATERIALS AND METHODS 
Source of Data                                                                                                                             
                The study was conducted in Tirunelveli Medical College Hospital, a 
tertiary care hospital. Hospital Ethical Committee approval was obtained. 
Patients scheduled to undergo elective surgery like lump excision, simple 
mastectomy, wide local excision, Webster procedure for gynaecomatia under 
TPVB with clonidine,as adjuvant to bupivacaine  were enrolled in this study. 
       This was a Prospective, randomized, comparative ,observer blinded  study 
 Inclusion criteria                                                                                                                        
1. Adult patients aged between 18-60 yrs.                                                                            
2. ASA I ,ASA II  physical status.  
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3. Diagnosed cases of simple breast disease.  
4. Patients scheduled for elective surgery like 
 Lump excision 
 Simple mastectomy 
 Wide local excision 
 Webster procedure for gynaecomatia 
 
Exclusion criteria 
 Patient refusal 
 Bleeding disorders.  
 Allergy to amide-type local anaesthetics.  
 Infection at  injection site.  
 Pregnant patient 
 Breast feeding females.  
 Severe obesity (BMI>35 kg/ m 2).  
 Psychiatric disorders.  
 Patients with past history of musculoskeletal disorders.  
 Additional surgical procedure during the same surgical time.  
 Previous history of thoracic or abdominal surgeries.  
SAMPLE SIZE 
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GROUP  BC( n-30)  - received 21 ml of  0.5% bupivacaine with clonidine                                                                        
(2 mics/kg) in Thoracic paravertebral block.  
GROUP   B (n-30)  - received 21ml of 0.5% bupivacaine with 1ml of isotonic    
normal saline  in thoracic paravertebral block.  
 RANDOMISATION 
Sixty consecutive adult patients were studied. 
 Informed Written consent  was obtained from all patients. 
The study population was randomized via sealed envelopes technique allocated 
into two groups as under-  
GROUP  BC was taken as  bupivacaine +clonidine group  
GROUP B was taken as bupivacaine group. 
PRE OPERATIVE EVALUATION  
In all the patients,  
 Age 
 I.P. No  
 Body weight and  
 Baseline vital parameters were recorded.  
 
History regarding Previous anaesthesia, surgery, Any significant medical 
illness,Medications and Allergies were recorded.  
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Complete physical examination and airway assessment were done.  
Following laboratory investigations were done 
 Haemoglobin %,  
 Blood sugar & urea  
 Serumcreatinine 
 Urine analysis.   
 Bleeding time and clotting time 
 
METHOD 
On the day of surgery, for patients coming  to theatre, intravenous access was 
obtained  using a 16 G or 18 G  intravenous canula, 5mL/kg/h infusion of 
Ringer Lactate fluid was started. 
All patients were premedicated  with midazolam 2mg iv and fentanyl 50 mics iv 
before performing block. 
HR, MAP and SpO2 were recorded before and after performing block.  
Technique:  
Monitoring: NIBP, ECG, SpO 2.  
Patient position: Sitting, Rt or Lt lateral decubitous 
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FIGURE - 9 Equipments 
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Equipments 
22 G  short bevelled Tuohy‟s epidural needle   
20 ml syringes (2 in nos) 
5 ml syringe with 1 ½ “ 25 gauge needle  for skin infiltration  
 Local anaesthetic agents- 0.5% Bupivacaine & 2% Lignocaine 
Clonidine ampoule   
Sterile towels and gauze packs   
Sterile gloves   
Marking pen  
Antiseptic solution for cleaning and painting of part 
Normal saline  
FIGURE – 10 Needle Insertion Point 
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Needle Insertion Point:  
       In breast surgery involved dermatomes T1-T6, 2-2.5 cm lateral to  tip of 
spinous process of corresponding T1-T6 vertebrae .  
FIGURE – 11 Performing   TPVB 
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PROCEDURE    
         Part was cleaned and painted with antiseptic solution.Sterile drapes were 
placed. Planned needle insertion point was infiltrated with local anaesthetic. 
Tuohy‟s epidural needle perpendicularly inserted from skin to hinge  transverse 
process at 3-5 cm depth. Syringe with prefilled  air  was connected to the 
Tuohy‟s epidural needle 
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                     From the tranverse process,needle is superiorly walked off, and 
advanced 0.5 to 1cm.On introduction loss of resistance to air could be  elicited.  
Syringe was detached from the needle and drug injected.In single level 
technique total volume of drug 21 ml was injected or in multiple level block    
3-4 ml of drug/dermatome was injected.  At the time of  injection , negative 
aspiration was done  to prevent  intravascular injection.  
Maximum dosage used was  3 mg/kg of body weight. Patient was then made to 
lie down supine .Onset of sensory anaesthesia occured 10 -15 minutes after the 
injection. 
Group  BC was injected with 21 ml of 0.5% bupivacaine with clonidine  (2 
mics/kg). 
Group  B   was injected with 21 ml of 0.5% bupivacaine with 1ml of normal 
saline. 
After the block patient was sedated  with intravenous opioids. 
Oxgenation with  facemask (4lit/min). 
In case of any block failure, patient  excluded from the study. 
                       Onset of  Sensory block,HR, MAP, and SpO2  were recorded 5, 
10,15,20, 30, 45,60, and 90minutes after the block and 1, 2, 4, 8, 12& 24hours 
after the end of  surgery.  
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Sensory block for each dermatomes was assessed by a pinprick test using a 3-
point scale:  
 Score 0 =normal sensation. 
 Score 1 =Absence of sensation of pinprick (analgesia).  
 Score 2 = Absence of sensation of touch (anaesthesia) 
 
               Onset of sensory block  time was defined as the time period between 
the end of the local anaesthetic administration to loss of touch sensation (score 
2) in each dermatomes.  
 Duration of sensory block is defined as the time period between the ends of 
local anaesthetic injection to complete recovery of anaesthesia on each 
dermatomes. 
               Duration of analgesia were  calculated from the end of local 
anaesthetic injection to the first complaint of pain.  
Visual Analog Scale (0 –10) was used for postoperative pain assessment Inj. 
diclofenac 75 mg i.m. was given when the Visual Analog Scale >4. 
 
Following  Complication of paravertebral block were observed in intraoperative 
and post operative period. 
 Failure of  block 
 Hypotension( less than 20% of baseline MAP) 
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 Bradycardia  (<55 bpm) 
 Pneumothorax. 
 Intrathecal injection, postdural puncture headache  
 Horner‟s syndrome, ipsilateral or bilateral. 
 Unilateral  arm sensory block (involved  to T1 component of 
brachial       plexus).   
 Hematoma. 
 Pulmonary haemorrege 
 Local anaesthetic toxicity. 
 
 
 
 
 
 
STATISTICAL ANALYSIS  
                    The observations recorded in each group were compared using 
statistical analysis. The raw data collected using the protocol was converted into 
grouped data . After the collection of  data, mean and  standard deviation was 
calculated for each variable in both the groups.   
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  If the two means in  two groups were found to be separated by more than twice 
of standard error(>2SE) then the two means were considered as highly 
significant (p<0.05).If the two means were found to be separated by more than 
thrice of standard error(>3SE),then the two means were considered as very 
highly significant(p<0.001).  
                  ANOVA, Student‟s paired t test were  used when data was normally 
distributed. The software used for calculation of p value was Stata (Version 10).          
 
 
 
 
 
 
 
OBSERVATION AND RESULTS 
                     The study was conducted in Tirunelveli Medical College Hospital. 
After obtaining approval from  the Hospital Ethical Committee, sixty patients 
were randomized into two groups. Group BC consisted of patients receiving 
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bupivacaine with clonidine in PVB while Group B consisted of patients 
receiving bupivacaine only . 
Randomisation was done using sealed envelope technique .After the completion 
of study, both the groups  were compared.  
        There were totall failure of block in 3 cases of which 2 in  Group  B and 1 
in Group BC. They were excluded from the study. In both the groups 
complications were not observed. 
 Age, weight of the patient and duration of surgery between both the groups 
were comparable and were not statistically significant (P>0.05) 
 
 
 
 
 
 
 
 
 
 
TABLE - 6 SEX DISTRIBUTION 
 
GROUP SEX FREQUENCY PERCENT 
BC GROUP 
MALE 3 10.0 
FEMALE 27 90.0 
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B GROUP 
MALE 3 10.0 
FEMALE 27 90.0 
 
 
 
 
CHART-1COMPARISION OF SEX DISTRIBUTION BETWEEN THE 
TWO GROUPS 
 
         
       Comparison of sex distribution between the two groups is statistically not 
significant 
Table – 7 Comparison of Age (yrs),Wt(kg) Distribution between the two 
groups 
PARAMETER GROUP FREQUENCY MEAN STANDARD 
DEVIATION 
p 
VALUE  
‘t’ 
0
5
10
15
20
25
30
BC GROUP B GROUP
SEX DISTRIBUTION
MALE FEMALE
81 
 
TEST 
AGE 
BC 30 32.90 11.260 0.832 
B 30 32.23 12.950 
WEIGHT 
BC 30 55.33 6.445 0.759 
B 30 55.87 6.922 
 
 
 
 
 
CHART – 2 Comparison of Age (yrs) Distribution between the two groups 
 
 
 
          
        
CHART – 3 Comparison of Wt(kg) Distribution between the two groups 
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               The mean age(yrs) and weight in kg of BC group was 32.9&55.33 and 
the B group was 32.33&55.87,the difference between two groups statiscally not 
significant (p>0.05). 
 
 
 
 
Table-8 COMPARISON  OF BASELINE PR, MAP,SPO2  BETWEEN    
THE TWO GROUPS 
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BASELINE 
PARAMETERS 
GROUP FREQUENCY MEAN STANDARD 
DEVIATION 
p 
VALUE  
‘t’ TEST 
PULSE RATE 
BC 30 83.267 0.3308 0.15 
 B 30 83.133 0.3039 
MEAN 
ARTERIAL 
PRESSURE 
BC 30 91.467 5.1214 
0.19 
B 30 91.533 5.4007 
SPO2 
BC 30 99.067 0.7849 
0.93 
B 30 99.367 0.5561 
 
CHART - 4 Comparison  of baseline parameters between the two groups 
 
 
 
                  
                     The  preoperative baseline PR ,MAP,SPO2 among the two groups 
comparison were statistically not significant(p>0.05). 
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Table - 9 Comparison of intra operative PR between two groups at various 
intervels. 
 
 
 
 
 
INTRA OP 
PULSE 
RATE 
GROUP FREQUENCY MEAN STANDARD 
DEVIATION 
p 
VALUE  
‘t’ 
TEST 
5 MIN 
BC 
30 83.367 5.4803 
.562 
 
B 30 84.167 5.1333 
10 MIN 
BC 
30 80.167 4.6984 
.493 
B 30 81.000 4.6535 
15 MIN 
BC 
30 75.867 4.5541 
.012 
 
B 30 78.700 3.8430 
20 MIN 
BC 
29 72.90 3.876 
.005 
 
B 30 75.80 3.727 
30 MIN 
BC 
29 69.93 3.380 
.001 
 
B 30 72.80 2.999 
45 MIN 
BC 
12 68.92 2.234 
 
.000 
B 14 73.79 2.607 
60 MIN 
BC 
5 70.40 2.702 
.003 
B 3 80.00 3.000 
END OF 
SURGERY 
BC 
30 72.167 2.6920 0.001 
B 30 78.400 5.3019 
85 
 
 
CHART – 5 Comparison of intra operative PR between two groups at 
various intervels 
 
    
           
 
 The mean intra operative PR was,lower in group BC ,Except 5
th
 and 
10
th
minute,when compared to group B.This was statistically  
significant(p<0.05)                                                                                                                                                                                                                                                                                                                                        
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Table - 10 Comparison  between two groups, intra operative MAP at 
 various intervels 
 
 
INTRA OP 
MEAN 
ARTERIAL 
PRESSURE 
GROUP FREQUENCY MEAN STANDARD 
DEVIATION 
p 
VALUE  
‘t’ 
TEST 
5 MIN 
BC 30 93.700 3.7614  
0.269 B 30 92.367 5.3465 
10 MIN 
BC 30 91.533 7.2194  
0.911 B 30 91.700 3.8070 
15 MIN 
BC 30 86.700 4.4810 0.027 
 B 30 89.033 3.3986 
20 MIN 
BC 30 78.633 5.8338 0.001 
 B 30 86.333 2.6436 
30 MIN 
BC 30 75.433 5.3991  
0.001 B 30 81.600 2.7241 
45 MIN 
BC 15 77.67 5.589  
0.329 B 14 79.21 2.045 
60 MIN 
BC 5 80.80 5.070 
0.802 
B 3 81.67 3.215 
END OF 
SURGERY 
BC 30 85.967 6.7949 
0.002 
B 30 81.167 3.9487 
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CHART – 6 Comparison of intra operative MAP between two groups at 
various intervals 
 
         
 
  The mean intra operative MAP was lower in group BC, Except 5
th
 and 
10
th
minute,when compared to group B.This was statistically  
significant(p<0.05). In  45
th
 and 60
th
 minutes p value is not significant,because 
frequency is small in both groups.      
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Table - 11 Comparison of intra operative SPO2 between two groups at 
regular intervals 
 
INTRA OP 
SPO2 
GROUP FREQUENCY MEAN STANDARD 
DEVIATION 
p 
VALUE  
‘t’ 
TEST 
5 MIN 
BC 30 98.600 .6747 0.155 
 B 30 98.333 .7581 
10 MIN 
BC 30 98.533 .5713  
0.140 B 30 98.233 .9353 
15 MIN 
BC 30 98.300 .9523  
0.354 B 30 98.500 .6823 
20 MIN 
BC 30 98.333 .7581 0.390 
 B 30 98.500 .7311 
30 MIN 
BC 30 98.867 .8193 0.253 
 B 30 98.667 .4795 
45 MIN 
BC 12 98.67 .492  
0.320 B 13 98.85 .376 
60 MIN 
BC 5 98.80 .447 
0.725 
B 3 98.67 .577 
END OF 
SURGERY 
BC 30 98.533 .6814 
0.385 
B 30 98.667 .4795 
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CHART - 7 Comparison of intra operative SPO2 between two groups at 
regular intervals 
 
 
 
               
 
The mean intraoperative spo2 is equal in both groups,statistically not significant 
(p>0.05) 
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Table – 12 Comparison of duration  of surgery between two groups 
 
 
PARAMETER GROUP FREQUENCY MEAN STANDARD 
DEVIATION 
p 
VALUE  
‘t’ 
TEST 
DURATION 
OF SURGERY 
BC 30 47.500 16.1218 0.933 
B 30 47.667 14.1259 
 
 
CHART-8    Comparison of duration  of surgery between two groups    
 
             
 
 
 
                  The mean duration of surgery  in group BC was 47.5 minutes and 
group B was 47.667,difference between both the groups was statistically not 
significant(p>0.05). 
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Table - 13   Comparison of post operative PR  between two groups at 
 various intervals 
 
POST OP 
PULSE 
RATE 
GROUP FREQUENCY MEAN STANDARD 
DEVIATION 
p 
VALUE  
‘t’ 
TEST 
1 HOUR 
BC 
30 74.400 4.9102 
0.002 
 
B 
30 78.633 4.9792 
2 HOUR 
BC 
30 77.967 4.3824 
 
0.002 
B 
30 81.533 3.9977 
4 HOUR 
BC 
30 82.733 4.6382 
0.001 
 
B 
30 87.000 3.5428 
8 HOUR 
BC 
30 80.833 5.1668 
0.001 
 
B 
30 91.400 3.5487 
12 HOUR 
BC 
30 83.500 4.7325 
0.001 
B 
30 93.667 4.0372 
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CHART -9  Comparison of post operative PR  between two groups at 
various  intervals 
 
 
 
 
 
 
                 The mean postoperative PR was,lower in group BC ,when compared 
to group B. This was statistically  significant(p<0.05).                                                                                                                                                                                                                                                                                                                                        
 
75
79
84 83
86
78
81
87
90
93
0
10
20
30
40
50
60
70
80
90
100
1 HR 2 HR 4 HR 8 HR 12 HR
P
U
LS
E 
R
A
TE
 
Axis Title
POST OP PULSE RATE
BC GROUP B GROUP
93 
 
Table - 14 Comparison of post operative MAP between two groups at 
various intervals 
 
POST OP 
MEAN 
ARTERIAL 
PRESSURE 
GROUP FREQUENCY MEAN STANDARD 
DEVIATION 
p 
VALUE  
‘t’ 
TEST 
1 HOUR 
BC 
30 78.633 5.8338 
0.001 
 
B 30 86.533 2.5289 
2 HOUR 
BC 
30 86.933 4.5177 
0.791 
 
B 30 87.200 3.1006 
4 HOUR 
BC 
30 89.400 5.1769 
0.719 
 
B 30 89.800 3.1666 
8 HOUR 
BC 
30 92.667 4.3098 
0.495 
 
B 30 93.300 2.6412 
12 HOUR 
BC 
30 91.867 5.8706 
0.001 
B 30 97.233 2.6611 
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CHART -10 Comparison of post operativeMAP  between two groups at 
various intervals 
 
 
 
 The mean of post operative MAP was low at 1HR and 12HR ,in group BC. It 
was  statistically significant , when compared with group B.  
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Table:15 Comparison of post operative SPO2 between two groups at  
 
various intervals 
 
 
 
POST OP 
SPO2 
GROUP FREQUENCY MEAN STANDARD 
DEVIATION 
p 
VALUE  
‘t’ 
TEST 
1 HOUR 
BC 
30 98.567 .6789 
0.849 
 
B 30 98.600 .6747 
2 HOUR 
BC 
30 98.600 .5632 
0.827 
 
B 30 98.633 .6149 
4 HOUR 
BC 
30 98.467 .8193 
0.609 
 
B 30 98.567 .6789 
8 HOUR 
BC 
30 98.600 .7240 
0.395 
 
B 30 98.733 .4498 
12 HOUR 
BC 
30 98.767 .4302 
0.303 
B 30 98.633 .5561 
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CHART11     Comparison of post operative SPO2 between two groups at      
various intervals 
 
 
 
        
 The mean postoperative spo2 is equal in both groups,statistically not significant 
(p>0.05). 
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Table - 16 Comparison of  ONSET OF SENSORY block between two 
groups 
 
PARAMETERS GROUP FREQUENCY MEAN STANDARD 
DEVIATION 
p VALUE  
‘t’ TEST 
ONSET OF 
SENSORY 
BLOCK 
BC 
 
 30 
8.937 .6403 
0.001 
B 
30 11.320 .4888 
 
CHART - 12 Comparison of  ONSET OF SENSORY block between two 
groups 
 
                                   The mean onset of sensory block was  8.937 minutes in 
group BC and 11.32 minutes in group B .When compared it was statistically  
high significant(p<0.05). 
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Table - 17 Comparison of  total duration  OF SENSORY block between 
two groups 
 
PARAMETERS GROUP FREQUENCY MEAN STANDARD 
DEVIATION 
p VALUE  
‘t’ TEST 
TOTAL 
DURATION 
SENSORY 
BLOCK 
BC 
30 616.867 64.2515 
0.001 
B 
30 465.167 48.0209 
 
CHART - 13 Comparison of  total duration  OF SENSORY block between 
two     groups 
 
 
                     The mean total  duration of sensory block was HIGH in group BC, 
when compared with group B. Its statistically  highly significant(p<0.01). 
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Table - 18   Comparison of duration of analgesia between two groups 
   
PARAMETERS GROUP FREQUENCY MEAN STANDARD 
DEVIATION 
p VALUE  
‘t’ TEST 
DURATION OF 
ANALGESIA 
BC 30 1098.000 117.3236 
0.001 
B 
30 713.000 86.5388 
 
CHART - 14 Comparison of duration of analgesia between two groups at 
various intervals.
 
                  The mean  duration of analgesia was  1098 minutes in group BC, and 
713 minutes in group B when compared, It was statistically  highly 
significant(p<0.05). 
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Table - 19 Comparison of VISUAL ANALOG SCORE for pain between 
 
 two    groups a various intervals 
  
VAS GROUP FREQUENCY MEAN 
RANK 
SUM OF 
RANKS 
MANN 
WHITNEY 
U TEST 
p 
VALUE  
‘t’ 
TEST 
1 HOUR 
BC 
30 27.00 810.00 
345.0 0.12 
B 
30 34.00 1020.00 
2 HOUR 
BC 
30 19.00 570.00 
105.0 0.001 
B 
30 42.00 1260.00 
4 HOUR 
BC 
30 16.55 496.50 
31.5 0.001 
B 
30 44.45 1333.50 
8 HOUR 
BC 
30 16.32 489.50 
24.5 0.001 
B 
30 44.68 1340.50 
12 HOUR 
BC 
30 16.08 482.50 
17.5 0.001 
B 
30 44.92 1347.50 
24 HOUR 
BC 
30 15.83 475.00 
10.0 0.001 
B 
30 45.17 1355.00 
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CHART - 15   Comparison of VISUAL ANALOG SCORE for pain 
 
 between two groups a various intervals 
 
 
        
 
  The mean of  VISUAL ANALOG SCORE was 1hr,2hr,4hr,8hr,12hr,24hr was 
low in group BC,when  compared with group B.Its  statistically significant 
(p<0.05) ,except 1hr VAS is not statistically significant.   
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Table - 20 Complication of PVB 
 COMPLICATION   Group BC  Group  B 
Faliure of block   1  2 
Bradycardia   -  - 
Hypotension   -  - 
Pneumothorax   -  - 
Vascular injection  -  - 
Intrathecal injection  - - 
-Local anaesthetic toxicity  -  - 
Unilateral Horners syndrome  -  - 
 
               
 
 There was totally  three cases of failed block ,in both the groups. 
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DISCUSSION 
                In our study we observed ,demographic datas  like age 
(yrs),sex,weight in(kg), ASA grade are not statistically significant ,when 
compared   in both groups. 
                          Diagnosis, procedure such as lumpectomy, excision, 
wepsterprocedure,simplemastectomy,and duration of surgery are not 
statistically significant , when compared both the groups. 
                         Addition of  clonidine with bupivacaine in thoracic 
paravertebral block,provided effective surgical anaesthesia and reduced  the 
onset of sensory blockade time.It  prolonged the total duration of sensory 
blockade time and also prolonged total duration of analgesia, when compared to 
control group. 
                   Patients had low postoperative VISUAL ANALOG SCORE in 
2HR,4HR,8HR.12HR,24HR. Patients were haemodynamically stable in both 
intraoperative and postoperative period and there was no bradycardia. 
                   The α 2 agonists dose dependently, enhance the potency and 
prolong  the duration of local anaesthetic  by combining  with α 2 receptors at 
peripheral level. The other action include  
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Vasoconstriction around the site of injection. Thus the absorption of local 
anaesthetic drug will be delayed, resulting in a prolongation of the local 
anaesthetic effect.  
         Clonidine directly inhibits the peripheral nerve action.  
         Release of local enkephalin like substances. 
        A decrease in the release of local inflammatory mediators. 
        Increase in the release of anti inflammatory cytokines.  
 
Clonidine and Dexmedetomidine are the currently used α 2 receptor agonists. 
                   In my study mean duration of analgesia is prolonged >18.3 HRS  in 
group BC, which is closely related to ,Weltz et al52  Fifteen patients with 
breast malignancies, who underwent surgical management under PVB, in the 
form of MRM with axillay dissection were studied retrospectively.  The onset 
of sensory blockade was prolonged upto 23 hrs effectively relieving post 
operative pain. 
                In study conducted by EbrahimyM&Moradi AR , in patients posted 
for simple mastectomy ,PVB with bupivacaine was used. Duration of analgesia 
was 17hrs and all patients observed no pain for the first 8hrs after surgery, 
which was comparable to my study. 
C. L. Burlacu ,H. P. Frizelle et al, studyobserved that, PVB with fentanyl and 
clonidine in combination  with levobupivacaine (0.05%) are effective 
105 
 
analgesics, a significant reduced  the supplemental postoperative morphine 
consumption after breast surgery. 
             In another study, HuraG,Knapik p et al,seventy patients receiving 
0.5%ropivacaine and 0.5% bupivacaine inPVB for MRM,  the onset of sensory 
blockade and duration of sensory blockade  was analysed.both the group similar 
level of analgsia was achived. Results shows that. 
     
    GROUP 
ONSET OF SENSORY 
BLOCKAE WITH IN 5 
MIN 
TOTAL DURATION OF 
SENSORY BLOCKADE > 24 
HRS 
       R                  53%         81% 
       B                  20%         50% 
 
                  In my study,  the mean  onset of sensory blockade time and total 
duration of sensory block in PVB,closely related to Pusch  F et al.study ,single 
injection unilateral PVB at the level of T4 , using 0.5% bupivacaine,in breast 
surgery. It produced faster onset and prolonged duration of sensory block (3 hr 
to 10 hr),and high post operative pain score. It  reduced the need for post 
operative analgesic doses. 
Coveney et al  - a retrospective study of 145 cases, who underwent  surgical 
treatment for breast malignancies using paravertebral block and 100 cases 
receiving   general anaesthesia alone. TPVB alone was enough for completing 
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the surgery in 85% of patients, while 5.7% of patients required supplementation 
with local anaesthetic. 
           In a study conducted by Greengrass et al ,twenty five patients 
underwent  breast surgery with paravertebral block and sedation  as an 
alternative to general  anaesthesia .Postoperatively , patients had minimal 
nausea , vomiting and pain. The procedure was satisfactory for all patients.   
 In a study conducted by Pekka et al  ,TPVB with 0.5% bupivacaine at the level  
T3,prior to general anaesthesia in patients posted  for breast canser 
surgery(MRM).only three patients had pain on the first postoperative day in 
comparison to the control group which had twelve patients with postoperative 
pain(p=0.007).In the 24 hour postoperative followup, VAS scores were higher 
in the control group in comparison to  the group receiving PVB block. 
Klein et al  , in their study  of sixty patients,   
found that patients receiving PVB experienced statistically significant less pain 
at 30 min, 1 hr, 24 hr and 72 hr in comparison to patients receiving GA only.      
           In our study,  no complication occurred in both groups,except for 3 
patients with  failure of blockade, similar to study conducted by Moller and 
Greengrass.           
Various studies on paravertebral blocks have quoted different rates of  
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complications.Terheggen  reported one case with epidural block and one 
patient with pleural puncture.     
Pekka  has reported a single incidence of accidental intravascular injection of 
bupivacaine. Coveney   has reported complication rate of 2.6% with two cases 
experiencing epidural extension while one patient developed pneumothorax. 
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CONCLUSION 
                           The addition of clonidine (2 mics/kg) to 0.5% bupivacaine in 
thoracic paravertebral block for simple breast surgery produced, faster  onset of 
sensory blockade.Its also prolonged the total duration of sensory block and 
duration of analgesia. It provided effective intraoperative and postoperative  
haemodynamic stability. 
From our study  we concluded that  
1. Paravertebral block  when used in alone provides effective surgical 
anaesthesia andsuperior analgesia in post operative period. 
2. Paravertebral block reduces incidence of postoperative nausea and vomiting 
3. Paravertebral block  provided effective intraoperative and postoperative 
haemodynamic stability. 
4. Paravertebral block leads to reduced hospital stay and early discharge. 
5. Complication rates of paravertebral block are significantly low thereby 
proving it to be a relatively safe procedure.              
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SUMMARY 
 In our study , 60 patients  receiveing  paravertebral block in breast surgery, 
were allocated into two groups ,group BC receiveing 0.5% bupivacaine with 
clonidine and group B 0.5% bupivacaine alone 
                             The addition of clonidine (2 mics/kg) to 0.5% bupivacaine in 
thoracic paravertebral block for simple breast surgery produced , faster onset of 
sensory blockade.It also prolonged  the total duration of sensory block and 
duration of analgesia. It provided effective intraoperative and postoperative  
haemodynamic stability. 
                     The procedure also proved to be safe as no complication was 
observed in patients, who received paravertebral block. 
                     So PVB was easy to learn , safe to perform  and patient friendly. 
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ANNEXURE – I 
CONSENT 
 
Informed written consent.  
 
Name of the patient-                                                        I.P. no-  
 
 
I ,------------ in my full sense give my wholehearted consent for the surgery 
under axillary brachial plexus block with levobupivacaine and 
dexmedetomidine for study purpose. I agree that no responsibility will be 
attached to the surgeon or anaesthetist. I have been explained about the 
procedure in my own language.  
 
 
 
                                                                    Signature of the patient / guardian  
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PROFORMA 
 
Case NO-                                                       I.P-no-  
 
NAME AND ADDRESS OF THE PATIENT  
 
 
 
Age- :                         Sex                                                   D.O.ADMISSION  
History in brief- 
  
Clinical diagnosis/ indication.  
 
Examination in brief-  
A. Vitals  
a. Pulse                         b .B.P                            C. AIRWAY-ASSESSMENT  
B. Systemic examination  
 
 
Baseline haemodynamics :  
PR:                                 BP:                                          SPO2:  
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INVESTIGATIONS  
Hb%             BT             CT            Blood urea              Serum creatinine  
RBS  
Urine examination- Albumin                  Sugar                       Microscopy  
 
Chest X-ray                                      ECG                                    ASA Grading-  
 
Surgical procedure -                                                             Duration-  
PARAMETERS OBSERVED-  
 onset time for sensory block -  
 Total duration of sensory block -    
 Duration of analgesia – 
Intra operative Monitoring: 
Time after block Heart rate MAP SPO2 
5 min    
10 min    
15 min    
20 min    
30 min    
45 min    
60 min    
90 min    
EOS    
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 Postoperative Monitoring: 
 
Time after 
surgery 
Hearte rate  MAP SPO2 VAS 
1HR     
2HR     
4HR     
8HR     
12 HR     
24 HR     
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S.N
O 
AGE SE
X 
WT DIAGNOSIS SX BASELINE INTRA OP PR INRAOP MAP  
PR MA
P 
SPO
2 
5M 10
M 
15M 20M 30M 45M 60M EOS 5
M 
10
M 
15
M 
20
M 
30
M 
45
M 
60
M 
EOS 
1 20 F 51 FA(LT) Excision 84 91 99 88 84 76 69 67 - - 72 93 86 84 77 79 - - 82 
2 22 F 48 FA(LT) Excision 79 95 100 85 80 76 72 69 - - 68 96 88 81 73 64 - - 78 
3 56 F 52 CA rt breast SM 90 102 97 91 88 84 76 70 67 70 74 97 93 87 88 76 73 82 98 
4 43 F 55 Phylloids  
tumor(rt) 
SM 90 97 98 81 78 76 73 70 68 69 73 98 101 97 90 84 82 77 97 
5 26 F 53 FA(RT) E 76 83 99 75 73 71 68 69 - - 68 89 101 87 76 69 - - 82 
6 35 F 56 FA(RT) E 81 90 99 77 74 70 67 64 69 - 71 91 84 88 76 78 72 - 85 
7 20 F 49 FA(RT) E 87 89 98 92 86 80 76 73 - - 76 96 87 84 79 77 - - 89 
8 19 F 45 FA(RT) E 84 96 99 87 85 79 77 75 - - 71 93 103 91 72 81 - - 87 
9 45 F 58 CA rt breast SM 92 99 100 81 80 77 76 74 69 67 74 87 82 84 76 72 78 88 101 
10 46 F 64 Phylloids tumor(lt) SM 89 90 100 91 87 84 81 77 74 72 76 97 88 84 76 74 85 82 89 
11 36 F 60 FA(RT) E 86 87 99 88 84 80  77 74 - - 70 89 88 84 76 76 - -- 84 
12 55 F 51 Phylloids tumor( 
rt) 
SM 90 97 99 96 88 86 80 75S 70 74 76 97 96 87 82 77 79 75 87 
13 29 F 54 FA(LT) E 78 92 98 81 78 74 69 67 - - 73 91 84 88 76 78 - - 76 
14 30 F 57 FA(LT) E 81 95 99 79 81 77 72 68 - - 69 96 88 81 73 64 - - 78 
15 29 F 58 FA(LT) E 84 86 100 82 80 74 68 66 - - 72 97 93 87 88 76 - - 77 
16 29 F 63 FA(RT) E 79 84 99 90 84 79 78 74 - - 70 98 101 97 90 84 - - 92 
17 29 F 65 Lump rt breast L 86 89 98 82 78 76 74 70 67 - 71 89 101 87 76 69 82 - 93 
18 47 F 48 FA(RT) E 82 93 99 78 75 71 68 64 - - 74 96 88 81 73 64 - - 89 
19 26 F 54 FA(RT) E 89 96 99 84 80 77 73 71 - - 68 97 93 87 88 76 - - 78 
20 22 M 68 Gynecomastia( lt) WP 78 97 99 80 77 75 72 69 66 - 74 98 101 97 90 84 82 - 86 
21 48 M 66 Gynecomastia(rt) WP 88 95 100 77 73 66 69 70 68 - 71 96 87 84 79 77 64 - 77 
22 23 F 45 Lump rt breast L 94 88 100 83 82 75 73 68 69 - 74 93 103 91 72 77 75 -- 79 
23 25 F 54 Lump lt breast L 90 82 99 89 87 82 78 76 72 - 78 87 82 81 76 72 78 - 82 
24 43 M 54 Gynecomastia(rt) WP 88 85 98 78 76 72 70 68 - - 70 97 88 84 76 74 85 - 84 
25 32 F 59 FA(RT) Excision 90 86 99 86 79 75 73 70 - - 76 89 88 84 76 76 73 - 78 
26 29 F 61 Lump rt breast L 87 87 99 74 71 69 64 66 68 - 70 97 96 87 82 77 79 - 89 
27 19 F 43 FA(RT) E 78 96 99 81 77 73 70 71 - - 69 91 84 88 76 78 - - 90 
28 23 F 52 FA(LT) E 82 99 100 85 82 74 72 69 - - 73 96 87 84 79 77 - - 87 
29 31 F 56 FA(LT) E 85 101 100 80 81 75 74 72 - - 71 93 103 91 72 81 - - 93 
30 50 F 61 FA(LT) E 88 77 100 80 77 73 69 67 - - 73 87 82 84 76 72 78 - 92 
  
  
 127 
 
 
INTRA OP SPO2 D
OS 
POST OP PR POST OP MAP POST OP SPO2 VAS OSB 
MIN 
TDSB 
MN 
DOA 
5
M 
10
M 
15
M 
20
M 
30M 45
M 
60
M 
EO
S 
1H 2H 4H 8H 12H 1H 2H 4H 8H 12H 1H 2H 4H 8H 12
H 
1H 2H 4H 8H 12H 24
H 
   
99 98 99 98 99 - - 99 35 68 78 80 77 88 77 84 86 87 91 98 99 99 97 99 0 1 1 2    3 4 7.9 665 1145 
98 99 99 98 99 - - 97 40 74 79 88 84 85 73 81 85 89 95 97 98 99 99 98 1 1 1 2 3 4 8.7 605 1210 
99 97 98 99 97 98 99 99 75 81 84 85 91 91 88 87 84 95 102 99 99 98 97 98 1 1 2 3 4 5 9.8 543 965 
97 98 99 98 99 99 98 99 80 83 78 86 89 81 90 97 93 97 101 98 99 99 99 99 1 1 2 3 4 5 9.7 485 945 
99 98 99 99 97 - - 98 35 75 77 81 78 75 76 87 78 83 83 99 98 99 98 99 0 1 1 2   3 4 8.6 670 1085 
99 99 98 99 99 99 - 98 55 78 83 75 73 85 76 88 87 89 90 99 98 99 99 99 1 1 1 2 3 4 7.8 710 970 
99 98 99 98 99 - - 99 40 76 86 77 76 83 79 84 91 95 89 98 99 97 99 98 1 1 1 2 3 4 9 698 1025 
98 99 99 97 98 - - 99 35 80 78 92 86 87 72 91 95 99 96 99 97 99 99 99 0 1 1 2 3 4 10 705 1155 
97 98 99 98 100 99 99 99 75 73 75 87 85 81 76 84 92 93 103 99 99 98 99 99 1 1 2 3 3 4 8.5 495 965 
99 99 99 99 99 98 99 98 85 69 78 81 86 91 76 84 88 87 90 99 99 99 97 98 1 1 2 3 4 5 8.4 590 970 
99 99 98 98 99 - - 99 35 72 79 84 87 88 76 84 89 97 87 99 98 99 99 99 1 1 1 2 3 4 8.2 610 1265 
99 99 97 99 100 99 99 99 80 78 71 81 84 92 82 87 83 89 97 97 99 99 99 99 1 1 2 2 3 4 9 578 1020 
99 98 99 97 99 - - 97 35 79 76 96 88 81 76 88 85 97 92 99 99 98 99 99 1 1 1 2 3 4 8 705 1215 
99 99 98 99 99 - - 99 40 69 78 81 78 79 73 81 87 91 95 99 98 97 99 99 1 1 1 2 3 4 8.1 550 1265 
98 99 96 97 99 - - 98 40 74 83 79 81 82 88 87 93 96 86 99 99 99 98 99 0 1 1 3 4 5 8.7 567 1135 
99 98 97 99 99 - - 99 35 68 75 82 80 90 90 97 99 97 84 99 99 97 99 99 1 1 1 2 3 4 8.5 613 1200 
99 99 98 99 100 99 - 99 50 75 77 85 84 82 76 87 96 98 89 97 99 96 99 98 1 1 2 2 3 4 8.3 497 1025 
99 99 98 99 97 - -- 98 40 79 78 82 78 78 73 81 93 89 93 99 98 99 99 99 1 1 1 2 3 4 9.3 570 1270 
99 98 99 99 99 - - 97 35 69 85 78 75 84 88 87 95 96 96 99 99 98 97 99 1 1 1 2 3 4 9.4 625 1085 
98 99 99 99 99 99 - 99 50 78 83 84 80 85 90 97 97 97 97 98 99 98 99 99   1 1 2 3 4 5 9.1 610 970 
99 99 97 98 99 99 - 99 55 71 77 80 77 84 79 84 89 90 95 99 99 99 98 99 1 1 1 2 3 4 9.2 595 1010 
99 98 99 97 99 98 - 98 55 83 78 77 73 83 72 91 86 93 88 99 98 99 99 99 1 1 1 2 3 4 9.4 620 945 
97 99 98 99 100 99 - 99 50 81 75 83 82 89 76 81 88 96 82 99 99 98 99 99 1 1 2 2 3 4 9 595 970 
99 99 96 99 98 - - 99 30 73 69 89 87 78 76 84 89 87 85 98 99 98 99 98 0 1 1 2 3 4 10 610 1140 
99 99 99 98 99 - - 98 40 70 73 78 76 86 76 84 87 97 86 99 98 99 99 99 1 1 1 2 3 4 9.5 710 1270 
99 98 99 97 99 98  99 55 79 74 86 79 74 82 87 90 89 89 98 99 99 99 99 0 1 2 3 3 4 9.6 685 980 
98 99 97 99 100 - - 99 35 69 72 79 71 81 76 88 79 87 102 99 99 99 98 99 0 1 1 2 3 4 9.7 645 1265 
98 99 99 98 99 - - 99 40 68 75 81 77 85 79 84 87 91 92 99 98 99 99 99 1 1 1 2 3 4 9.4 625 1150 
99 98 99 99 98 - - 98 35 72 87 85 82 78 72 91 95 96 95 98 99 99 99 98 0 1 1 2 3 4 8.4 655 1245 
99 98 99 98 99 - - 99 35 68 78 80 81 79 76 91 96 93 86 99 98 99 99 99 1 1 1 2 3 4 8.9 675 1080 
S.N
O 
AGE SE
X 
WT DIAGNOSIS SX BASELINE INTRA OP PR INTRA OP MAP 
PR MAP SPO 5
M 
10M 15M 20M 30M 45M 60M EOS 5M 10
M 
15
M 
20
M 
30M 45
M 
60
M 
EOS 
1 24 F 52 FA(RT) Excision 88 93 99 84 80 78 73 72 - -  78 102 95 93 88 84   - - 82 
2 20 M 48 Gynecomastia(rt) WP 85 96 100 91 87 85 83 78 75 - 79 95 97 96 93 87 80 - 78 
3 42 F 61 Lump breast (rt) L 76 88 100 90 88 87 85 81 77 - 84 99 93 89 86 80 77 - 80 
4 18 F 40 FA(RT) E 81 89 100 86 84 81 77 73 - - 78 90 89 87 85 76 - - 77 
5 40 F 56 Lump breast(rt)  L 82 89 99 77 75 76 72 68 72 - 78 89 95 93 90 82 78 - 76 
6 40 F 58 Lump breast(lt)  L 84 91 99 85 82 79 79 75 74 - 83 96 99 91 89 86 82 - 80 
7 19 F 54 FA(RT) E 92 90 98 88 82 77 74 76 - - 79 103 93 90 87 83 - - 81 
8 18 F 45 FA(RT) E 87 93 99 78 74 76 73 71 - - 78 90 87 89 86 80 - - 78 
9 45 F 66 FA(LT) E 81 87 100 79 81 79 76 74 77 - 85 87 86 81 82 78 76 - 82 
10 25 F 67 FA(RT) E 86 97 100 85 81 76 76 73 - - 78 97 96 87 85 80 - - 78 
11 21 F 50 FA(RT) E 88 89 99 84 80 82 78 75 - - 79 92 90 89 87 82 - - 80 
12 20 F 55 FA(LT) E 82 92 99 92 87 84 81 76 - -  71 95 91 89 86 81 - - 77 
13 56 F 52 Ca breast( rt) SM 91 94 99 88 85 80 77 73 75 80 93 86 89 85 82 77 81 84 93 
14 18 F 59 FA(RT) E 79 96 99 75 78 74 72 69 - - 78 84 85 87 84 79 - - 77 
15 48 M 71 Gynecomastia(lt) WP 82 92 100 79 77 73 74 72 70 - 76 89 87 84 85 80 77 -- 78 
16 26 M 64 Gynecomastia(lt) WP 90 91 100 95 89 84 81 75 74 - 75 93 89 90 89 84 80 - 82 
17 24 F 54 FA(RT) E 82 89 99 87 85 80 79 73 -- - 77 96 92 89 87 82 - - 80 
18 58 F 59 Ca breast (lt) SM 78 96 99 81 74 72 69 71 76 83 92 97 97 90 87 85 82 78 85 
19 18 F 46 FA(RT) E 87 92 100 84 79 75 73 70 - - 77 95 90 87 85 80 - - 78 
20 24 F 55 FA(LT) E 76 90 99 79 77 79 74 71 - - 75 88 93 87 85 81 - - 86 
21 52 F 58 Phylloids tumor(rt) SM 87 95 99 84 82 78 73 71 73 77 86 87 90 85 82 80 78 83 90 
22 38 F 59 Lump breast (rt) L 83 93 100 79 83 79 76 74 76 - 78 85 87 93 87 84 82 - 86 
23 35 F 62 Lump breast (lt) L 78 87 99 89 87 83 79 78 74 - 75 86 97 90 89 82 78 -- 81 
24 36 F 64 FA(RT) E 84 97 99 78 77 76 74 70 - - 69 89 89 85 84 80 - - 84 
25 31 F 52 FA(LT) E 86 89 100 78 75 73 71 72 - - 73 98 87 89 85 81 - - 85 
26 45 F 56 Lump breast (lt) L 74 90 99 91 89 84 79 70 68 - 74 92 91 89 87 84 80 - 78 
27 54 F 55 Lump breast (rt) L 85 91 99 81 75 79 74 69 72 - 77 95 96 91 87 82 78 - 81 
28 23 F 48 FA(RT) E 79 90 100 85 77 75 72 70 - - 75 88 93 96 90 86 - - 82 
29 27 F 58 FA(LT) E 81 93 100 88 82 80 76 73    - - 76 87 95 93 89 84 - - 80 
30 22 F 52 FA(LT) E 80 87 99 85 78 77 74 71 - - 76 101 93 87 82 78 - - 80 
 
 INTRA OP SPO2 D
OS 
POST OP PR POST OP MAP POST OP SPO2 VAS OSB TDSB DOA 
5M 10
M 
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M 
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M 
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M 
EO
S 
1H 2H 4H 8H 12H 1H 2H 4H 8H 12
H 
1H 2H 4H 8H 12
H 
1H 2H 4H 8H 12H 24
H 
 
98 99 98 97 99 - - 99 35 78 82 84 93 92 88 91 95 97 99 97 99 99 98 99 1 1 2 3 4 5 11.2 485 835 
99 98 99 99 98 99 - 98 50 77 83 90 95 99 93 89 88 93 97 99 99 98 99 98 1 2 3 4 5 7 11 440 660 
97 99 98 99 99 98 - 99 55 84 80 86 92 94 86 85 86 90 93 99 98 99 99 99 1 2 3 4 5 6 10.8 395 645 
99 97 99 98 99 - - 98 40 78 83 87 93 96 85 87 90 93 99 97 99 99 98 99 1 2 3 4 5 6 10.9 410 690 
99 98 99 99 98 99 - 99 50 78 81 86 91 89 90 93 95 97 99 99 99 99 99 98 1 2 3 4 5 6 11.4 445 705 
97 99 99 98 99 99 - 99 55 83 87 94 99 96 89 88 86 90 97 99 99 98 99 99 1 1 2 3 4 5 11.7 490 865 
99 98 98 99 99 - - 98 35 79 81 86 93 95 87 85 89 93 97 98 98 99 99 99 1 1 2 3 4 5 11.5 460 790 
98 99 99 98 99 - - 99 40 78 82 88 90 89 86 87 93 96 99 99 99 97 99 99 1 2 3 4 5 6 12 525 695 
99 97 98 99 98 99 - 99 50 85 86 89 93 95 82 79 86 87 89 99 98 99 99 99 1 2 3 4 5 6 10.6 515 590 
98 99 99 98 99 - - 98 40 78 78 83 85 89 85 83 89 93 97 98 99 99 98 99 1 1 2 3 4 6 10.9 490 745 
98 96 99 99 98 - - 99 40 79 80 85 90 94 87 89 91 95 99 99 98 99 99 98 1 2 3 4 5 6 11 445 610 
97 99 98 99 99 - - 99 35 71 77 87 91 98 86 89 93 95 96 99 99 98 99 99 0 1 2 3 4 5 11-4 500 845 
99 97 99 97 99 98 99 98 80 89 93 93 96 101 82 87 93 97 102 99 99 99 99 98 1 2 3 4 5 7 11.3 395 545 
99 99 98 99 99 - - 99 40 78 80 86 93 95 84 89 88 93 97 99 97 99 98 99 1 2 3 4 5 6 12 385 615 
98 98 99 99 98 99 - 99 50 76 78 83 89 90 85 85 86 90 93 99 99 99 99 98 1 2 3 4 5 7 12.3 470 660 
99 98 99 97 99 99 - 99 55 75 79 93 95 99 89 87 90 93 99 99 99 98 99 99 1 2 3 4 5 6 12.5 445 710 
97 99 98 99 99 -- - 98 35 77 80 88 93 95 87 93 95 97 99 98 99 99 99 98 1 2 3 4 5 7 11.4 470 740 
99 98 99 99 98 99 99 99 85 92 89 94 97 100 87 88 86 90 97 99 99 99 98 99 1 1 2 3 4  6 116 375 595 
98 97 99 99 99 - - 99 40 77 80 85 90 95 85 85 89 93 97 99 97 99 99 99 1 2 3 4 5 6 11 490 680 
99 99 98 97 99 - - 99 35 75 79 86 93 94 85 87 93 96 99 99 99 98 99 97 1 2 3 4 5 6 10.9 510 720 
99 96 99 99 99 99 98 98 85 86 90 88 94 97 82 84 87 93 10
1 
98 99 99 98 99 1 2 3 4 5 6 10.8 380 585 
98 99 99 98 99 99 - 99 55 78 82 89 87 86 87 83 89 93 97 99 98 99 99 99 1 2 3 4 5 6 11.3 465 650 
99 99 97 99 99  - 99 50 75 81 87 95 99 89 89 94 96 94 99 99 99 99 99 1 2 3 4 5 6 11.4 520 730 
97 98 99 99 98 - - 98 35 70 76 90 89 94 84 87 89 93 99 98 99 97 99 98 1 2 3 4 5 6 12 505 725 
99 98 99 98 99 - - 99 40 73 77 79 85 89 85 89 88 93 97 99 98 99 98 99 1 1 2 3 4 6 11.4 540 830 
98 99 98 99 99 99 - 99 50 74 78 87 91 88 87 85 86 90 93 99 99 99 99 99 1 2 3 4 5 6 11.7 485 770 
99 98 99 99 98 99 - 98 55 77 81 86 89 90 87 87 90 93 99 99 98 99 98 99 1 2 3 4 5 6 10.8 490 790 
99 99 97 99 98 - - 99 35 75 78 81 85 89 90 93 95 97 99 98 99 97 99 98 1 2 3 4 5 6 10.7 410 750 
98 99 99 98 99   - - 99 40 80 83 84 87 90 88 88 86 90 97 99 99 98 99 99 1 2 3 4 5 6 10.9 525 825 
98 99 97 99 98 - - 98 40 84 82 86 89 93 89 85 89 93 97 97 99 98 99 98 1 2 3 4 5 6 11.2 495 795 
